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Abstract 
Chinese discovered the beneficial effects of mushrooms for more than 2000 years. 
Nevertheless, it is not until 1960s, the antitumor effect of mushroom polysaccharides 
was scientifically determined. Though the mechanism responsible for their tumoricidal 
effects is not fully understood, it is believed they exhibit their effect via the modulation 
of host immune system. However, polysaccharides isolated from different mushroom 
species are different in their efficacy against tumor in vitro and in vivo. Therefore, it is 
worthy to develop novel polysaccharides with therapeutic properties from some 
recently introduced mushroom strains and further explore their antitumor mechanisms 
at the cellular as well as molecular levels. 
In this study, three polysaccharide fractions (TAP 1, 2 and 3) were extracted from 
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the golden ear Tremella aurantialba, a fiingus with medicinal efficacy in China. Their 
antitumor effect was investigated by in vitro and in vivo methods. The induction of 
mRNA expression of cytokines and nitric oxide synthase in splenocytes and peritoneal 
exudates cells of the BALB/c mice by the fraction with most prominent antitumor 
effect was also studied to determine its immunomodulatory effects. 
In both in vitro and in vivo studies, the fraction with most prominent antitumor 
effect was TAP 2. After 72 h incubation in vitro, TAP 2 (200 ^g/ml) could significantly 
i 
inhibit the proliferation ofHL-60 (44%), MCF-7 (20%) and HepG2 (33%) cancer cell 
lines. On the other hand, intraperitoneal injection of TAP 2 (4mg/kg) for 10 
consecutive days could also inhibit the growth of Sarcoma 180 solid tumor 
transplanted into BALB/c mice by 73.3%. 
The investigation of mRNA expression level of cytokines and nitric oxide 
synthase in TAP 2-treated male BALB/c mice showed that TAP 2 was capable of 
upregulating the mRNA expression ofTNF-a, IL-ip and nitric oxide synthase in both 
splenocytes and peritoneal exudate cells, which might be a result of macrophage 
activation. Besides, the upregulation of IL-12 p35 and p40 mRNAs were observed in 
splenocytes of TAP 2-treated mice. 
These findings indicate that TAP 2 with the most effective antitumor effect might 
activate macrophages to produce TNF-a, IL-lp and nitric oxide in order to kill the 
tumor cells directly or indirectly in vivo. Future studies may focus on forther 









爲TAP 1, 2和3�此硏究以一連串體外及體內實驗，選擇最有抗腫瘤功效的多糖 
部份，其對調節免疫能力的影響，則會以BALB/c小鼠脾臟細胞及腹腔滲出細胞 
的細胞因子及一氧化氮合成_之mRNA _程度再作進一步的硏究。 
、 體外及體內的抗腫瘤實驗顯示，金耳多糖TAP 2是三個部份中最有效的。經 
過三天體外培養’ TAP 2 (200 lag/mL)能有效地抑制HL-60 (40%)，MCF-7 (20%) 
及HepG2 (32%)三種癌_胞的生長。另外，腹腔注射TAP 2 (4 mg/kg X 10天） 
能有效地抑制BALB/c小鼠Sacroma 180肉瘤的生長達73.3%� 
另一方面，TAP 2也可以提升雄性BALB/c小鼠的免疫能力。實驗結果顯示， 
TAP 2可增加BALB/c小鼠脾臟細胞及腹腔滲出細胞之TNF-a, IL-1P及一氧化氮 
合成_的mRNA表達程度，這些細胞因子及骑的mRNA提升’有可能是TAP 2 
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Current antineoplastic agents used clinically are usually cytotoxic to normal 
cells. Considerable side effects such as decrease in the number of leucocytes, damage 
to liver, spleen or other vital organs, loss of body weight and appetite are common in 
cancer patients who received chemotherapy or radiotherapy (Jong & Donovick， 
1989). There is a strong eagerness to search for novel tumoricidal drugs that are more 
specific to cancer cell with less or even no detrimental side effects. The use of 
mushroom polysaccharides with prominent antitumor activities in the last few 
decades seems to be one of the alternatives to the conventional anticancer drugs. 
They have the advantage due to their low toxicity towards normal cells. In Japan, 
several mushroom polysaccharides are commercially available, such as PSK and 




Hundreds of mushroom polysaccharides have been extracted during last thirty 
years. Most mushroom polysaccharides isolated in early years are pure glucan having 
a p-1,3-glucan backbone and 1,6-branchs, e.g. lentinan (Chihara, 1992). Later on, 
heteroglycans (Mizuno et al.’ 1999) and polysaccharide-protein complexes 
(Tsukagoshi et al.’ 1984) with tumoricidal effect from mushrooms are also isolated. 
They are varied in their chemical structures and antitumor activities (Mizuno, 1999; 
Ooi & Liu，2000). Their molecular weight (Falch et ciL’ 2000), degree of branching 
(Ohno et ai, 1986), structural conformation (Chihara et al” 1970a; Chihara, 1992) 
and even the route of administration (Ohno et ai, 1986) may affect their antitumor 
effect. 
Direct cytotoxicity of mushroom polysaccharides towards cancer cells in vitro is 
rare. Though there are some exceptions like, PSK (Tsukagoshi et al., 1984) and 
� - � 
PSPC (Liu et aL, 1996b). PSPC for example, is a protein-bound polysaccharide 
complex isolated from Thcholoma lobayense (Liu et al., 1995). At a dose of 60 
[ig/ml，PSPC can significantly inhibit the proliferation of four cancer cell lines: 
HL-60, Pu 5-1.8, H3B and melanoma (Liu et al, 1996b). 
Antitumor activities of mushroom polysaccharides are usually determined by in 
vivo methods. Although there are no standard procedures to study the antitumor 
effect in vivo, basic procedures are more or less the same. The researchers implanted 
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selected cancer cell line into particular strain of mice for tumor development. The 
mushroom polysaccharides are administered to the tumor-bearing animal for a period 
of time. Then, the tumor-bearing mice are killed at the end of experiment and the 
inhibition ratio is calculated by comparing to the control. The effect of mushroom 
polysaccharides may vary. The source they are isolated, the strain of experimental 
animals (Suga et al., 1984; Liu et al., 1995) and dose of mushroom polysaccharide 
administered (Ohno et aL，2000) will all affect the result obtained. 
Until now，the mechanism of how these mushroom polysaccharides can inhibit 
tumor growth is not fully elucidated. However，most researchers believe that they act 
as immunomodulatory agents or biological response modifiers, which are able to 
modulate the host immune system to fight against tumor in order to restore the 
homeostasis of the body. This indirect mode of action may explain why most 
mushroom polysaccharides do not possess anticancer effect in vitro but significant 
anticancer effect are observed when they are incubated with cells isolated from 
immune system in vitro. 
The research done by Zhang and Lin (1999) can serve as one of the examples. 
They use the polysaccharide fraction GL-B isolated from the Ganoderma lucidum to 
incubate with T cells or macrophages. After incubation, the culture medium was then 
added to HL-60 cells in vitro, apoptotic peaks are observed in the DNA histograms 
•o-
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as analyzed by flow cytometry. However，GL-B does not show direct anticancer 
effect on HL-60 in vitro. The authors claim that GL-B may stimulate the T cells and 
macrophages to produce cytokines such as, interferon-y (IFN-y) and tumor necrosis 
factor-a (TNF-a) which account for its tumoricidal activity (Zhang & Lin, 1999). 
Mushroom polysaccharides can stimulate the immune cells to secret 
cytokines, proteins which play an important role in the communication within the 
immune system (Kelso, 1998). There are many types of cytokines. The screening of 
target cytokine responsible for the mushroom polysaccharide action seems to be a 
big problem. The development of molecular biology definitely helps us understand 
more about the mechanism of antitumor mushroom polysaccharides at the molecular 
level. Various researches have been done on the analysis of cytokine mRNAs 
induction by polysaccharides isolated from different mushrooms using 
reverse^transcriptase assisted polymerase chain reaction，RT-PCR in short (Nemoto 
et al, 1994; Ohno et aL, 1996; Liu et a/., 1996a & 1999b). The cytokine mRNAs can 
be isolated from target immune cells (e.g. peritoneal exduate cells and splenocytes) 
and with the aid of suitable primers, the expression level of a variety of cytokines can 
be determined at a relatively short period of time. 
In addition to cytokines, nitric oxide (NO) also plays an important role in the 
immune system. This minute molecule serves as a messenger acting on macrophages 
-4-
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in an autocrine manner to enhance their phagocytic activities against bacteria and 
cancer cells. Besides, NO is also cytotoxic to bacteria and cancer cells (Anbar, 1995). 
The synthesis of NO by macrophage involves an inducible enzyme, NO synthase 
(NOS). Therefore, the upregulation ofNOS mRNA suggests that active production 
of NO is involved. Ohno et al (1996) have reported a (l->3)-p-D-glucan extracted 
from Ghfola flxmdosa (GRN), which is capable of inducing the production of nitric 
oxide (NO) by activated macrophage. However, the production of NO stimulated by 
GRN requires the presence oflFN-y. 
In this thesis Tremella aiirantialba was selected as the source of mushroom 
polysaccharide. It is an edible mushroom belonging to the class Basidiomycetes and 
Tremellaceae family (徐錦堂，1997). It is also known as a kind of traditional 
Chinese medicine having a moderate warm and cold nature. (Hobbs, 1995). The 
administration of Tremella aurantialha extracts to the animal models produce 
hepatoprotective, immunopotentiating, anti-aging and anti-inflammation effects have 
been reported 嶺堂，1997). Recently, some researchers have isolated an acidic 
polysaccharide from Tremella aurantialha which has potent hypoglycemic activity 
and promotes glucose metabolism in the liver (Kiho et aL, 1995, 2000a & 2000b). 
In this thesis, the antitumor effect of the polysaccharide fractions isolated from 
the Tremella aurantialha was studied. In vitro and in vivo experiments were 
-5-
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performed to find out the most effective fractions as well as its optimum dose. The 
effective fractions would be intraperitoneally injected into the animal models. The 
regulation of mRNA expression level of nitric oxide synthase and particular 
cytokines in the splenocytes as well as peritoneal exduate cells by effective fractions 
would be investigated by RT-PCR. Speculations of how the effective polysaccharide 





2.1 Mushroom Polysaccharides with Antitumor Activities 
Mushroom has a long medicinal history in China. The traditional Chinese herbal 
therapists have known the miraculous medicinal effect of mushrooms for 2000 years. 
In a very famous Chinese Materia Medica “Shen Nong Ben Cao Jing"(神農本草經） 
written around 200B.C. to 200 A.D., mentioned the medical value of a mushroom 
called “Ling Zhi”（靈芝).This mushroom is now called Ganoderma lucidum 
taxonomically and is still used in Chinese herbal medicine in the present day. It has a 
variety of therapeutic applications, such as treating bronchial cough in elderly 
persons, insomnia and carcinomas (Hsu, 1986). 
In addition to Ganoderma lucidum, some mushrooms we consume as food also 
have medicinal uses from the "traditional Chinese medicine" point of view. Tremella 
fiiciformis, for example, its fruiting bodies are not only a delicious dish but also a 
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kind of herbal medicine used for nourishing the stomach and lung yin (陰）in China 
(Bensky et al., 1993). 
What constituents in mushrooms account for their medicinal effect? The 
numerous polysaccharides isolated during the past few decades might answer the 
question. Though the mechanism behind is still not fully understood, scientists 
believe mushroom polysaccharides exhibit their effect through the modulation of 
host immune system. They have been proven to exhibit a variety of pharmacological 
activities, such as antitumor (Mizuno et cd； 1999), antiviral (Tochikura et al., 1987)， 
anti-diabetic (Kiho et al., 1995) and free radicals scavenging activities (Liu et al., 
1997). 
Since the aim of this thesis is to study the antitumor effect of a particular 
mushroom, the following paragraphs will focus mainly on those mushroom 
polysaccharides that possess antitumor activities. 
Although the term "mushroom" is used to describe the source of these antitumor 
polysaccharides, they are not only confined to the fruiting bodies of higher fungi that 
can be distinguished by unaided eye (Ooi & Liu, 2000). Active components may be 
isolated from the fruiting bodies (Ohno et al., 2000), mycelia (Mizuno et al. 1999), 
or even spore (Bao et al., 2001) of fungi. Even though most of them belong to 
Basidiomycetes (e.g. Lentinus edodes\ antitumor polysaccharides extracted from 
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ascomycetes (e.g. Corcfyceps sinensis) were also reported (Kiho et al,, 1993). The 
structural characteristics and pharmacological activities among these mushroom 
polysaccharides are diverse. However, they can be divided into three major classes 
based on their constituents of monosaccharides (Ooi & Liu, 2000): (1) (3-glucans, 
their basic constituents are glucose only; (2) heteroglycans, they composed of a 
variety of monosaccharides such as mannose, galactose or glucose, etc.; (3) 
polysaccharide protein complexes, which have a polysaccharide portion composed of 
either heteroglycans or glucose only (Table 2.1). 
2.1.1 Antitumor P-GIucans 
Beta-glucans are a kind of polysaccharides composed of glucose only. Perhaps 
they are the class of mushroom polysaccharides being most extensively studied. 
Some of the examples of antitumor p-glucans include, polysaccharide isolated from 
Lentinus edodes (Chihara et al.，1970b) named lentinan, OL-2 of Omphalia 
lapidescens (Ohno et al, 1992) and schizophyllan of Schizophyllan commune 
(Komatsu^/ . , 1969). 
These antitumor p-glucans have high molecular weight and usually consist of a 
1,3-p-D-glucan backbone with variable degree of 1,6-p-D-glucopyranoside 
branching. For example, lentinan, a fungal p-glucan extracted from the fruiting body 
-9-
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Table 2.1 Examples of mushroom polysaccharides possessing antitumor effects 
Name of 
Mushroom Class Reference 
polysaccharide 
Grifolafnmdosa Grifolan NMF-5N p-glucan Ohno et al., 1985 
Lentimis edodes Lentinan P-glucan Chihara ^r^/., 1970b 
Schizophyllum commune Schizophyllan p-glucan Komatsu 已广"/.，1969 
Omphalia lapidescens OL-2 P-glucan Ohno et al.. 1992 
Sparassis crispa SCCA, SCHA p-glucan Ohno et ai，2000 
Agahcus blazei FA-lb Heteroglycan Mizimo et al，1999 
Armillahella tahescens AT-HW Heteroglycan Kiho et al, 1992a 
Tremella fuciformis TP Protein bound heteroglycan Zhang & Hong, 1984 
Coholus versicolor PSK Polysaccharide protein complex Tsukagoshi et al, 1984 
Tricholoma lobayense PSPC Polysaccharide protein complex Lmetal, 1996b 
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of Lentinus edodes, is a glucan capable of treating cancer particularly in GI tract 
(DerMarderosian, 2001). Lentinan is a highly pure p-D-glucan with molecular 
weight of 400-800 kDa. It has a right-handed triple helical molecule with a repeating 
unit composed of a linear chain of five 1,3-p-D-glucan coupled with two 1,6 
branches (Chihara etaL, 1970b; Sasaki & Takasuka, 1976; Chihara, 1992). 
In addition to fruiting bodies, antitumor p-glucans can also be isolated from the 
mycelia of flingi. For example, a p-glucan extracted from the matted mycelium of 
Ghfolajrondosa (Ohno et al.，1985). This polysaccharide Grifolan NMF-5N, is also 
a 1,3-P-D-glucan with 1,6 branches. Recently, antitumor P-glucan isolated from the 
spore of Ganoderma lucidum was reported (Bao et aL，2001). The structure of this 
fxjgal spore polysaccharide is much more complex than conventional fungal 
(3-glucans. Although it also consists of a 1,3-P-D-glucan main chain, the side chains 
at the C-6 glucosyl unit are composed of mono-, di- and oligosaccharides. 
2.1.2 Antitumor Heteroglycans 
Apart from the polysaccharides composed only of glucose, there are antitumor 
polysaccharides consists of several different monosaccharides, such as mannose, 
xylose, glucose, uronic acid, etc. to form heteroglycans. Some of them are true 
heteroglycans such as those isolated from Agaricus hlazei (Mizuno et al,, 1999) and 
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Armillariella tabescens (Kiho et al.，1992a). 
The heteroglucan FA-lb isolated from the liquid-cultured mycelium oiAgaricus 
blazei has a molecular weight of more than 2000 kDa by Sepharose 4B gel filtration. 
FA-lb is a highly branched glucomannan consisted of a 1,2-|3-D-mannopyranosy 1 
main chain and |3-D-glucopyranosyl-3-0-p-D-glucopyranosyl branches. It can 
significantly inhibit the growth of Sarcoma 180 solid tumor (Mizuno et al., 1999). 
FA-lb is a heteroglycan composed of two kinds of monosaccharides only (glucose 
and mannose). In fact，antitumor heteroglycans composed of three or even more 
different kinds of monosaccharides are common. For example, the AT-HW (105 kDa) 
isolated from the Armillariella tabescens is a polysaccharide composed of glucose, 
galactose, mannose and flicose (Kiho etal., 1992a). 
2.1.3 Antitumor Polysaccharide-Protein Complexes 
In addition to some true p-glucans and heteroglycans, some of the antitumor 
polysaccharides isolated from certain mushrooms are coupled with proteins to form 
polysaccharide-protein complexes (Ooi & Liu’ 2000). PSPC and PSK, for instance, 
are polysaccharide-protein complexes isolated from the Tricholoma lohayense (Liu et 




The polysaccharide-protein complex extracted from a local mushroom, 
Thcholoma lobayense (Liu et ai, 1995; Liu et al.’ 1996b) called PSPC, is a 154 kDa 
heteroglycan-protein complex extracted from the culture filtrate of the fungi. It is 
capable of inhibiting the growth of ascites or solid tumor of Sarcoma 180. It 
possesses 40% of polysaccharide (w/w) consisting fUcose, galactose, glucose， 
mannose and arabinose. The protein moiety occupies 30% (w/w) of PSPC and 
contains 15 different amino acids. 
perhaps one of the most well known examples of polysaccharide-protein 
complex is PSK, which is already an important nutraceutical market item in Japan 
(Mizuno, 1999). PSK is isolated from the deep-layer cultivated mycelium of 
Corioliis versicolor (Tsukagoshi et aL, 1984). The average molecular weight of PSK 
is 94 kDa as estimated by ultracentriflige analysis. PSK has a 1,4-P-D-gliican main 
chain and 1,6-P-gIucopyranosidic branches coupled with a glutamic acid and aspartic 
acid rich protein residue. Although glucose is the main constituent in the 
polysaccharde fraction, small amount of galactose, fUcose, mannose and xylose are 
present in PSK (Tsukagoshi et aL, 1984). A similar polysaccharide complex called 
PSP of molecular weight 100 kDa is isolated from submerged culture of Coriolus 
versicolor by Chinese scientists. PSP has a very similar structure as PSK, though 
arabinose and rhamnose are found in PSP. Both PSK and PSP show prominent 
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antitumor effects. PSK is already used clinically in Japan for treating cancer of 
digestive organ, lung and breast. They all show excellent antitumor effect for treating 
allogeneic tumor such as Sarcoma 180 and Ehrlich carcinoma in vivo (Tsukagoshi et 
al. 1984., Ng, 1998). 
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2.2. Antitumor Activities and Structural Characteristics of Mushroom 
Polysaccharides 
The molecular weight, degree of branching and conformation of mushroom 
polysaccharides may affect their antitumor activities. However, there are no straight 
rule governing the relationship between these structural features and the antitumor 
effect of mushroom polysaccharides (Ooi & Liu，2000). Many researches aimed at 
clarifying the structural function relationship have been done and sometimes 
contradict results obtained. The following are only some of the examples of how 
antitumor effects are modulated by the difference in structural properties. 
Most mushroom polysaccharides possessing antitumor activities require high 
molecular weight. Some mushroom polysaccharides will produce their effect over a 
certain threshold of molecular weight. For example, a paper analyzes the effects of 
heteroglycans of Tremella fuciformis on cytokine production from human monocytes 
(Gao et al, 1996a), which is believed to be responsible for antitumor activities. 
Three heteroglycan fractions have been isolated from Tremella fuciformis. They are 
capable of stimulating the production of cytokines interleukin-1 (IL-l), interleukin-6 
(IL-6) and tumor necrosis factor-a (TNF-a) from human monocytes. One of the 
fraction, Tla was ftirther hydrolysed to yield five fractions with molecular weight, 
26,000, 22,000, 15,000, 6,000 and 1,000 respectively. The fraction with the smallest 
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molecular weight showed a decrease in extent in inducing human monocytes to 
produce lL-6. Gao et al. (1996a) concluded that “a degree of polymerisation of at 
least 7 was required for the cytokine stimulating activity and the activity was caused 
by the common partial structure of Tla” 
Although most antitumor polysaccharides with a high molecular weight possess 
antitumor effect, higher molecular weight polysaccharides may not always show 
higher ability in antitumor activitiy. In a recent study (Falch et al 2000), the cytokine 
stimulating activity of scleroglucan from Sclerotium was shown to be induced by a 
1,3-P-glucan with a triplex helix structure. Scleroglucan with molecular weight lower 
that 50x104 g/mol or larger than 110x10^ g/mol could stimulate human monocytes to 
produce TNF-a better than those ranging from (67-110) xlO^ g/mol. In this case, the 
cytokine stimulating activity is not directly proportional to the increase of molecular 
mass. 
On the other hand, the degree of branching may also affect the antitumor ability 
of a mushroom polysaccharide. For example, OL-2 isolated from the Omphalia 
lapidenscens is a P-glucan having two 1,6 banches at every third unit of the main 
chain. Its antitumor effect is compared with a similar P-glucan, GRN from Grifola 
frondosa having a degree of branching of 1/3 (Ohno et al, 1986). When GRN and 
OL-2 were intraperitoneally injected into Sarcoma 180 solid tumor bearing mice at a 
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dose of 100 ng/mouse, the tumor inhibition ratio ofGRN was 94% while OL-2 was 
only 29%. However, when OL-2 was injected intralesionally, the inhibition ratio was 
elevated to 73% (Ohno et al. 1992). Ohno et al. (1986) claimed that OL-2 was 
definitely another mushroom polysaccharide with antitumor effect, the difference in 
degree of branching may account for the difference in OL-2 antitumor activity. 
The higher structure of a mushroom polysaccharide may also affect its 
antitumor effect. One of the most well known examples is Pachyman. Pachyman is a 
(1—3)-P-D-glucan extracted from Poha cocos. It did not possess any antitumor 
effects when compared to other P-glucans (e.g. lentinan). Researchers claimed that 
this might be due to the difference in structure between the two glucans: pachyman 
has a single helical structure whereas lentinan had a triple helical structure. However, 
when pachyman was chemically modified to form glucans with triple helical 
structure (pachymaran, carboxy-methyl-pachymaran and U-pachyman), they could 
produce significant inhibition effect on Sarcoma 180 solid tumor (Chihara et al, 
1970a; Chihara, 1992). Chihara (1992) claimed that "such structure-activity 
relationships suggest the existence of biological systems within the human body 
which recognize the configurational structures of polysaccharides". The presence of 
this kind of receptor is already proven by numerous researches (Czop & Kay, 1991; 
Poutsiaka et al, 1993; Duan et al., 1994; Elstad et al” 1994). 
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However，it is not the case in schizophyllan. In 1995, Ohno et 以/.prepared two 
conformers from schizophyllan，one is triple helix conformer and the other is single 
helix conformer. Antitumor and immunopharmacological activities between these 
two conformers were investigated. The results are quite interesting. Both conformers 
could inhibit the solid tumor growth and produce hematopoietic response. However, 
the triple helix conformer is more effective in antagonizing the effect of zymosan 
than that of the single helix. On the other hand，the single helix conformer has a 
stronger activity in priming effect of lipopolysaccharide triggered tumor necrosis 
factor synthesis, nitric oxide synthesis of peritoneal macrophage in vivo and 
hydrogen peroxide synthesis of peritoneal macrophage in vivo. "These facts strongly 
suggested that the glucan-mediated immunopharmacological activities were 
dependent on the helical conformation, and the conformation dependency varied 
� - � 
dependent on the assays used，，(Ohno et al.’ 1995). 
The above examples show that the structural properties certainly affect the 
antitumor activities of mushroom polysaccharides. In addition, other factors such as 
the route of drug administration and the methods in evaluating their biological 
activities may also affect the result obtained. 
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2.3 Antitumor Effects of Mushroom Polysaccharides In Vitro 
Most mushroom polysaccharides do not show direct cytotoxic effect towards 
cancer cell lines in vitro. For example, when a partially purified polysaccharide from 
Ganoderma lucidum-GL-B (molecular weight: 7000-9000) was incubated with 
Sarcoma 180 and HL-60 (50-400 |ig/ml) for 72 h, it showed no 
effects in vitro but slightly increased the proliferation of HL-60 cell line at 400 jig/ml 
(Zhang & Lin, 1999). 
On the other hand, TP extracted from the Tremella fuciformis also does not have 
significant antitumor effect in vitro. TP is a protien-binding polysaccharide 
consisting of a polysaccharide moiety of mannose, glucuronate, xylose, fructose and 
glucose. It has a molecular mass of 300 kDa and is water-soluble (Zhang & Hong, 
1984). When TP is incubated with Ehrlich carcinomas in vitro and its effect is 
� 
determined by ^H-thymidine incorporation, no significant difference between 
TP-treated cells and those of the control group was observed at dose 1 mg/ml (Zhou 
et aL, 1987). 
Though mushroom polysaccharides exhibit antitumor effects in vitro are rare, 
there are some exceptional cases. For example, PSK and PSP isolated from Coriolus 
versicolor can effectively inhibit the growth of various kinds of cancer ceil lines. For 
example, PSK can inhibit the proliferation of Ehrlich carcinoma, Yoshida sarcoma 
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and AH-13 in vitro (Tsukagoshi et a/., 1984), while PSP can inhibit the growth of 
Sarcoma 180，Ehrlich carcinoma and leukemia P388 (Ng, 1998). 
On the other hand，PSPC mentioned previously also shows distinctive antitumor 
effect in vitro. When PSPC (60 jig/ml) was incubated respectively with four cancer 
cell lines, HL-60, melanoma, Pu 5-1.8 and H3B for 24 h in vitro, it could 
significantly inhibit the growth of HL-60 (63.8%)，Pu 5-1.8 (83.1%)’ H3B (96.4%) 
and melanoma (38.1%) (Liu et al., 1996b). 
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2.4 Antitumor Effects of Mushroom Polysaccharides In Vivo 
Many mushroom polysaccharides have prominent antitumor effect in vivo. 
Although there are no standard procedures to study the antitumor effect in vivo, basic 
procedures are more or less the same. The researchers implant selected cancer line 
into particular strain of mice. The most commonly used cancer cell line and strain of 
animal is Sarcoma 180 and BALB/c mice respectively. The mushroom 
polysaccharides are administered to the animal for an interval of time, such as 10 
consecutive days. Then, the tumor-bearing mice are killed and the inhibition ratio is 
calculated by comparing to the control. For example, Grifolan NMF-5N isolated 
from the Ghfola frondosa at a dose of 100 ^ig/mouse was intraperitoneal injection 
into ICR mice for 10 days. It could significantly inhibit the Sarcoma 180 solid tumor 
by 97% on the 35 days after tumor transplantation (Ohno et cd., 1985). On the other 
hand, the antitumor effect of TP isolated from Tremella fuciformis was investigated 
by Zhou et cd. (1987). TP of dose 1 mg / 10 g of mouse body weight was i.p. injected 
into mice bearing Ehrlich ascite tumor for 9 consecutive days. On the 12 day after 
tumor inoculation, the tumor inhibition ratio was determined to be 42% (Zhou et al., 
1987). 
Though mushroom polysaccharides can effectively inhibit tumor growth in vivo, 
their effects varied among different strains of mice, the dose of mushroom 
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polysaccharide and the route of drug administration. 
The strain of mice used in in vivo study may produce a different result. For 
example, when lentinan is administered into three strains of mice, A/J, C3H/He and 
C57BL/6 respectively, the responses are different. When lentinan at a dose of 4 
mg/kg was i.p. administered into the mice for ten consecutive days, it could 
significantly inhibit the growth of Sarcoma 180 in A/J mice by 96.5% and 9 out of 10 
of them showed complete regression of tumor. However, in C3H/He and C57BL/6 
mice, tumor inhibition rates were only 36.2% and 51.8% respectively. Moreover，no 
complete regression of tumor was observed in these two strains (Suga et al., 1984). 
Moreover, strain difference in mice may also affect the efficacy of mushroom 
polysaccharide. The antitumor effect ofPSPC, for instance, was tested in vivo among 
male ICR and BALB/c Sarcoma 180-bearing mice. Both strains of tumor-bearing 
�� 
mice received 20 mg/kg ofPSPC for 10 consecutive days. A higher inhibition ratio 
on tumor growth were observed in ICR mice (96%) than BALB/c mice (50%) (Liu et 
a!., 1995). 
Usually, the antitumor effect of mushroom polysaccharides increases as their 
dose increases. For example, an increase in dose of GL-B from 50 to 200 mg/kg 
administered to Sarcoma 180 bearing BALB/c mice would increase the inhibition 
ratio from 27.7% to 66.7%. However, sometimes the inhibition on tumor growth will 
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be lowered at high dose. Two polysaccharide fractions from the cultured fruit body 
of Sparassis crispa, SCHWElv and SCCAl were tested for their antitumor effect in 
vivo (Ohno el al., 2000). The polysaccharide fractions of dose 20, 100 and 500 
(ig/mouse respectively were i.p. injected into ICR mice on the 7，9 and 11 days after 
Sarcoma 180 tumor transplantation. SCHWElv increased inhibition ratio on 
Sarcoma 180 solid tumor from 83.6% to 99.5% as the dose increased. However, 
SCCAl had a highest inhibition percentage on tumor growth at dose 100 |ig/mouse 




2.5 Immunomodulatory Activities 
Although the mechanism of mushroom polysaccharides is not fully elucidated, 
most researchers believe these antitumor polysaccharides are actually biological 
response modifiers or immunomodulatory agents that exert their actions through the 
activation of immune cells (e.g. macrophages，T cells etc.) and induce the production 
of multiple cytokines and/or activation of the complement system in order to restore 
the homeostasis of the host immune system. 
Numerous findings supporting these speculations by different approaches have 
been published (Maeda & Chihara, 1971; Chihara, 1992). For example, in order to 
prove that the antitumor effect is dependent on the presence of T cells, lentinan was 
administered to the neonatally thymectomized mice. The loss of important immune 
organ for T-cell development caused loss in tumor regression ability. Moreover, the 
antitumor effect of lentinan is also inhibited by pretreatment with anti-macrophage 
agents such as silica, indicating the immune cells like T-cells and macrophages take 
parts in the mechanism against tumor by lentinan (Maeda & Chihara, 1971; Chihara, 
1992). 
In 1992, Chihara suggested that the components in host immune system are 
regulated by mushroom polysccharide through the elevation of various bioactive 
serum factor such as acute-phase protein-inducing factor, interleukin 3 (IL-3), colony 
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Stimulating factors (CSFs)，etc. might be one of the pathways. On the other hand, 
lentinan could activate the complement system in order to augment the non-specific 
cytotoxicity of macrophages and infiltration of neutrophils into tumors. Possible 
mode of action proposed by Chihara (Fig. 2.1) also suggests that lentinan can 
activate various cells in the immune system to produce cytokines which induce a 
cascade of events that eventually lead to the restoration of specific and nonspecific 
cellular and humoral immune reactivity of the tumor-bearing host in order to achieve 
its antitumor effect (Chihara, 1992). 
Jn vitro study of mushroom polysaccharides also proves that they can modulate 
the cell in immune system. For instance, GL-B from the Ganoderwa lucidum does 
not show direct antiproliferation effect on HL-60 cell line in vitro. However, when 
the culture medium which have been used to culture T cells or macrophages in the 
presence of GL-B are added to HL-60 cells, apoptotic peaks are observed in the 
DNA histograms analyzed by flow cytometry (Zhang & Lin，1999). The authors 
claim that GL-B may stimulate the T cells and macrophages to produce cytokines 
into the cultured medium. The cytokines, as they suggest，may contain tumor 
necrosis factor-a (TNF-a) and interferon-y (IFN-y), which are responsible for the 
induction ofapoptosis in HL-60 (Zhang & Lin, 1999). 
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The heteroglycans of Tremella fuciformis are also proved to have cytokine 
stimulating activities (Gao et al., 1996a & 1996b). Human monocytes isolated from 
human A+ blood buffy coat and incubated with the heteroglycans for 24 h. A range 
of 62 \ig/m\ to I mg/ml of the drugs is incubated with the monocytes for 24 h. The 
harvested cell-free medium is used for the analysis of interleukin-l (IL-1), 
interleukin-6 (lL-6) and TNF content. The results showed that the heteroglycans 
from Tremella fuciformis are capable of stimulating the production of IL-1, IL-6 and 
TNF regardless of their changes in molecular weight or dose, provided that a certain 
threshold is achieved. 
On the other hand, the polysaccharide-protein complex from Tremella 
fuciformis is capable of promoting the lymphocyte proliferation induced by 
concanavalin A (Con A) in mice. ConA-induced proliferation was measured by 
[^H]TdR incorporation into lymphocyte from mouse spleen cells of C57BL/6j mice 
receiving TP of doses range from 50-200iig/ml. The result shows that TP can also 
significantly increase the ConA-induced lymphocyte proliferation in a 
concentration-dependent manner (Xia & Lin, 1989). 
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2.6 Activation of Cytokines by Mushroom Polysaccharides 
Cytokines play an important role in the communication within immune system 
(Kelso, 1998), Mushroom polysaccharides are believed to be capable of regulating 
these "signals" in order to exhibit their antitumor effects. Therefore, to study the 
mechanism behind their antitumor activities, we must first determine how they 
regulate the cytokines in the host immune system. However, there are several 
families of cytokines and each family constitutes a number of cytokines (Kelso, 
1998). The analysis of the regulation of cytokines by mushroom polysaccharides 
using methods like enzyme-linked immunoabsorbent assay (ELIZA) can only study a 
few numbers of cytokines at the same time. Sometimes different methods have to be 
used in order to identify particular cytokines responsible for their antitumor 
mechanism within numerous kinds of cytokines in host. For example, the 
investigation of the presence of TNF-a and IFN-y in T cells and macrophages 
incubated with GL-B were done by two methods (Zhang & Lin，1999). The presence 
of TNF-a was determined by L929 bioassay whereas IFN-y was evaluated by 
solid-phase enzyme-linked immunoabsorbent assay (ELIZA) (Zhang & Lin’ 1999). 
The development of molecular biology has definitely solved the problem and 
helped us understand more about the mechanism of antitumor mushroom 
polysaccharides at molecular level. Various reports analyzed the regulation of 
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cytokines mRNAs expression by mushroom polysaccharides in experimental animals 
using reverse-transcriptase assisted polymerase chain reaction, RT-PCR have been 
published (Nemoto el aL, 1994; Liu et d.，1996b; Ohno et aL, 1996). The cytokines 
mRNAs can be isolated from the target immune cells (e.g. peritoneal exudate cells 
and splenocytes) and with the aid of suitable specific primers, the expression level of 
a variety of cytokines can be determined by the same method at a relatively short 
period of time. For example, the mRNA expression of cytokines in mice 
administered with OL-2 extracted from Omphaiia lipidescense were compared with 
those administered with schizophyllan from the Schizophyihim commune using 
RT-PCR by Nemoto ei al. (1994). OL-2 couid significantly induce mRNA of 
granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony 
stimulating factor (GM-CSF) whereas schizophyllan could significantly induce the 
mRNA of interleukin-3 (TL-3) (Nemoto et cd., 1994). These findings indicated that 
the mechanism governing activation of hematopoietic system between the two 
polysaccharides are different. Besides, although both OL-2 and schizophyllan could 
upregulate the expression of mRNA of cytokines, IL-la，TL-ip, TNF a and 
macrophage-colony stimulating factor (M-CSF), the kinetics and pattern of cytokine 
gene expression are different in organs (i.e. spleen, peritoneal cell and liver) and 
glucans. Nemoto et al. (1994) claimed that it is possibly due to the difference in the 
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distribution of glucans and the soluble factors released from the organs by the 
glucans. They concluded that the changes in the kinetics would be related to both the 
accumulation of phagocytes, granulocytes and lymphocytes in the organs and 
activation of these cells (Nemoto et al., 1994). 
On the other hand, RT-PCR studies of polysaccharide-protein complexes, PSPC 
and PSK showed that they can upregulate the mRNA expression level of 
macrophage-colony stimulating factor (M-CSF) in peritioneal exudate cells and 
splenocytes (Liu et al., 1996a). However, only PSK can increase the expression level 
of TNF-a. Liu et al. (1996a) believed that M-CSF can promote the maturation of 
haemopoietic cells as well as potentiate the macrophage tumoricidal and phagocytic 
activities. 
The kinetics of cytokine genes regulated by PSPC and lentinan were also 
compared by Liu et al. (1999). At different time intervals (0, 3, 6，12, 24 and 48h) 
after the adminstration of PSPC or lentinan (20 mg/kg), the total RNA were isolated 
from peritoneal exudate cells and splenocytes of experimental animals, and the 
expression levels of cytokine mRNAs were determined by RT-PCR. The expression 
of IL-lP, TNF-a, IFN-y and M-CSF mRNAs were detected in peritoneal exudate 
cells as well as splenocytes. Induction of these cytokine mRNAs seemed to begin at 
3 or 6 h after PSPC or lentinan administration. Both IL-l p, TNF-a and M-CSF 
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remained high over a period of time while IFN-y was only upregulated for a short 
period of time. Their expression levels varied at different time intervals, the drug 
administered and the cell where they were isolated. The above examples show that 
mushroom polysaccharides might regulate the cytokine expression at gene 
transcription level. Though many mushroom polysaccharides can stimulate the 
expression of cytokine genes, the kinetic was different among different 




2.7 Induction of Nitric Oxide Synthase by Mushroom Polysaccharides 
Nitric oxide (NO) is a small compound having a variety of functions in 
biological system. In central nervous system, it plays a role as a neurotransmitter 
(Anbar, 1995). In circulatory system, it plays an important part in vasodilation (Xie 
et al., 2000). In immune system, it serves as a messenger acting on macrophages in 
an autocrine manner in order to enhance their phagocytic activities against bacteria 
and cancer cells. Besides, NO is also cytotoxic to bacteria and cancer cells (Anbar, 
1995). In the following paragraphs, some examples will be given to show mushroom 
polysaccharides can stimulate NO production. 
The production of reactive nitrogen intermediate was studied in mice 
administered with PSP of Coriolus versicolor by Liu et al (1993). Peritoneal 
macrophages obtained from mice pretreated with PSP were allowed to react with 
Griess reagent. The reactive nitrogen intermediates were determined by comparing 
the absorbance (540nm) with standard. The result showed that PSP could increased 
the production of nitrogen intermediates by 2-fold. On the other hand, a single helix 
conformer of a polysaccharide called sonifilan extracted from Schizophyllum 
commune-SVYi-OYi, could stimulate the production of NO in vivo (Ohno et al., 
1995). If SPH-OH was i.p. administered into ICR mice once and the peritoneal 
exudate cells (PEC) were collected 4 days later，the results showed that SPH-OH 
-32-
Literature Review 
could significantly increase NO production of PEC by nearly thirty-fold. 
The production of NO by macrophage is synthesized by an inducible enzyme, 
NO synthase (NOS), via stimulation of particular cytokines. Therefore, the 
upregulation of NOS suggests that active production of NO is involved. Recently, 
Ohno et al (1996) have reported the relationship between the expression of IFN-y 
mRNAs with NO production regluated by GRN using RT-PCR methods. GRN is a (1 
—3)-P-D-glucan extracted from Grifola frondosa, aside from its cytokines inducing 
ability, it is also capable of inducing the production of nitric oxide (NO) by activated 
macrophage. This minute soluble factor is synthesized by an inducible NO synthase 
present in the activated macrophage and it is toxic to tumor cells (Roitt et al., 1998). 
When the production of NO was analysed by using peritoneal cells isolated from the 
GRN-treated mice and incubated for 24-48 hours, the level of NO was elevated 24 
�� 
hours after administration and remained high for two weeks. However, direct 
activation of macrophage by GRN to produce NO could not be achieved in vitro 
unless IFN-y was present. Generally, IFN-y are secreted by THl cells or natural killer 
(NK) cells (Roitt et aL, 1998). As the antigen presentation has not been induced by 
the assay system in the paper described, the authors suggested that the GRN 
mediated enhancement of NO synthesis by peritoneal macrophages was due to the 
activation of macrophages by IFN-y from NK cells (Ohno et al., 1996). 
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2.8 Tremella aurantialha 
In this thesis, Tremella aurantialha was selected as the source of mushroom 
polysaccharide. It is an edible mushroom belongs to the class Basidiomycetes and 
family Tremellaceae (徐錦堂，1997). In traditional Chinese medicine, Tremella 
aurantialha Bandoni et Zang (or Tremella aurantia Schw,ex Fr.)(陳士瑜及陳海英， 
2000) “is moderately warm and cold in nature, taste sweet, nourishing, regulates Qi, 
stops coughing and can be used in asthmatic attacks, reduces phlegm and supports 
the liver" (Hobbs, 1995). 
The administration of Tremella aurantialha extracts to the animal models 
exhibited hepatoprotective, immunopotentiating, anti-aging and anti-inflammation 
effects (徐錦堂，1997). Recently, some researchers have isolated an acidic 
polysaccharide from Tremella aurantialha (Kiho et aL, 1995, 2000a & 2000b). They 
found that the polysaccharide has potent hypoglycemic activity and can lower the 
plasma cholesterol level in normal and diabetic mice by promoting glucose 
metabolism in liver (Kiho et al, 1995，2000a & 2000b). 
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Chapter 3 
Materials and Methods 
3.1 Extraction 
3.1.1 Extraction of Crude Tremella aurantialba Polysaccharide 
Dried form of Tremella aurantialba (Fig. 3.1a) was purchased from the local 
herbal dealer. The sample was washed and soaked in 2 L distilled water. The soaked 
sample (Fig. 3.1b) was extracted by boiling distilled water (5 L) in a slow cooker 
overnight. The insoluble components in the boiled sample were removed by filtration. 
Four volumes of 95% ethanol were poured into the filtrate collected with mixing to 
precipitate out molecules with high molecular weight, especially polysaccharides. The 
mixture was left undisturbed at 4 overnight. The precipitates formed were collected 
by centrifligation at 15,600 g for 30 min with the aid ofBeckman J2-MI centrillige and 
a JA-14 rotor. The pellets were re-dissolved in distilled water. The insoluble 
components were removed by centrifligation (15,600 g, 30 min) 
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(a) 
(b) 
Fig. 3.1 (a) Dried form of Tremella aurantialba and (b) Soaked Tremella aiirantialha 
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Tremella aurantialha (204 g) 
Soaked in 2 L distilled H2O 
i 




added 4 vols of 95% ethanol (4。(：, overnight) 
Precipitates collected by centrifugation (15,600 g, 30 min) 
> f 
Redissolve in distilled H2O 
> f 







muted with H2O ^TAP 1 
i  
Ehited with 0.04 MNaCl ^ TAP 2 
> f 
Eluted with 0.1 M NaCl ^ TAP 3 
Fig. 3.2 Flow chart illustrate the extraction of Tremella aurantialha polysaccharide 
fractions 
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and lyophilized. The pale yellow freeze-dried product was designated as the crude 
extract of Tremella aurantialba polysaccharides (TAP). 
3.1.2 Fractionation 
Fractionation of crude TAP was performed by anion exchange chromatography. 
Fifty milligrams of the freeze-dried TAP was dissolved in distilled water. The sample 
was applied to a 1.8x20 cm DEAE-celkilose anion exchange column which was 
pre-equilibrated with distilled water. The flow rate was 30 ml/h and the fractionation 
was collected at 6 ml/tube. The presence of polysaccharides in every fraction was 
determined by phenol-sulfuric assay (detailed in Section 3.1.3.1). Stepwise eiution of 
distilled water, 0.04 M and 0.1 M NaCl solutions was performed in order to obtain 
TAP fractions 1,2 and 3 respectively (Fig. 3.2). TAP 2 and TAP 3 were dialyzed (pore 
size of dialysis tubing: 12-14 kDa) against distilled water extensively at 4 
3.1.3 Polysaccharide and Protein Content Determination 
The content of polysaccharide in crude TAP and TAP fractions was determined 
by phenol-suifliric assay (Dubois et aL, 1956; Harris et al, 1995). On the other hand, 
the amount of protein in the fractions was determined by Lowry-Folin method (Lowry 
et al, 1951; Waterborg & Matthews, 1994) 
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3.1.3.1 Phenol-Sulfuric Assay (Dubois et al., 1956; Harris et al” 1995) 
Phenol-sulfliric assay is a simple and rapid method. Addition of phenol and 
concentrated sulfuric acid to sugar sample produces a stable orange-yellow color with 
intensity directly proportional to sample's polysaccharide quantity. Therefore, with the 
aid of a suitable standard (e.g. glucose), the approximate quantity of polysaccharide in 
the TAP fraction could be determined. In this study, the sample was dissolved in 
distilled water and 200 of sample were mixed with equal volume of 5% phenol in 
distilled water. 1 ml of concentrated sulfuric acid (98.8 g/mol) was added to the surface 
of liquid rapidly. The reaction mixture was left undisturbed for 10 min at room 
temperature for color development. Following vigorous mixing, the tubes were 
allowed to stand for another 30 min. The absorbance was measured by Miiton Roy 
Spectronic 3000 photodiode spectrophotometer at wavelength 490 nm. Blank and 
standard curve are prepared following the same procedure, using distilled water and 
mannose solution (0-70 j^g/ml) respectively. 
3.1.3.2 Lowry-Folin Method (Lowry et al, 1951; Waterborg & Matthews, 1994) 
Sample in distilled water of concentration 1 mg/ml was prepared. Equal volume 
of 2 N NaOH was added to 100 }il sample. The mixture was hydrolyzed for lOmin at 
100�C and allowed to cool down to room temperature. Freshly prepared complex 
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forming reagent (1 ml) (detailed later) was added to the solution and incubated at room 
temperature for 10 min. Then, 0.1 ml ofFolin and Ciocalteifs phenol reagent (BDH) 
was added to the mixture with vortex. Finally, the reaction mixture was left 
undisturbed at room temperature for 30 min. Absorbance of the mixture was detected 
by Milton Roy Spectronic 300 photodiode spectrophotometer at wavelength 750 nm. 
The standard curve was prepared by using different concentration (0-500 {ig/mi) of 
bovine serum albumin (Sigma) following the same protocol. 
Complex forming agent was freshly prepared before use by mixing 2% (w/v) 
NaiCOs, 1% (w/v) CUSO4.5H2O and 2% (w/v) sodium potassium tartrate in a ratio of 
100:1:1 (v:v:v), respectively. 
3.1.4 Gas Chromatography (GC) 
�� 
Gas chromatography was used to quantify and identify the neutral 
monosaccharide composition in each TAP fraction. In other to determine the 
monosaccharide composition in TAP fractions, TAP 1,2 and 3 were first subjected to 
acid hydrolysis. About 13 mg of sample was hydrolyzed by 0.7 mL sulfuric acid (12 
M). After 1 h incubation at 35 ^C water bath with stirring, the hydrolysate was diluted 
6-fold with distilled water. The diluted solution was heated in boiling water bath with 
continuous shaking for an hour and then cooled to room temperature. 
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The alditol acetates of the neutral and amino sugars were prepared using 3 ml ot 
hydrolysate according to the method described by Blakeney et al (1983). p-D-allose 
(1 mg/mL) was used as the internal standard. Determination of neutral sugars by gas 
GC was performed by HP6890 gas chromatography equipped with an Alltech DB-225 
capillary column (15 m x 0.25 mm i.d., 0.25 [im film thickness). The oven temperature 
program was run as follow: initial temperature, 180 ^C with 4 ^C/min rise to 220 ^C 
and held at 220 for 30 min. Helium gas was used as the carrier gas. Fiame 
ionization was used for detection and the injection volume of each sample was 2 |iL. 
The amount of monosaccharide present in sample was expressed as relative percentage 
by weight (%w/w). 
3.1.5 Modified Carbazoie Assay (Bitter and Muir, 1962; Harris et al” 1995) 
The gas chromatography method used in Section 3.1.4 can only determine the 
neutral sugar composition in the sample. However, for acidic polysaccharide fractions 
like TAP 2 and 3, acidic monosaccharide residues, that is, uronic acid may also 
presence. Thus, in this study, modified carbazoie assay was also performed to 
determine the uronic acid content in the three TAP fractions. 
In this assay, 0.5 mi sample (25fig/ml) was gently added to 5 volumes of 
sodium tetraborate decahydrate (0.025 M) in concentmted sulfuric acid. The content 
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was mixed thoroughly with frequent cooling before heated to 100 °C for 10 mm. The 
mixture was then cooled and 02 ml carbazole (0.125 %) in ethanol was added to the 
mixture iind heated to 1 0 0 � � again for 15 min. Absorbance was detected by Milton 
Roy Spectronic 3000 photodiode spectrophotometer at wavelength 530 run. Blank and 
standard curve were prepared following the same procedure, using distilied water and 
D-gaiaciuroninc acid (Sigma) (0-40 }.ig/mi) respectively. 
3丄6 High Performance Liquid Chromatogmphy (HPLC) 
Samples (2 yig) were dissolved in 0.5 MNaCl solution and filtered Ihrough a 0.22 
[im filter. KPLC was performed using ihe HPLC system in Biology, CUHK using TSK 
gel™ column G5000PW (30 cm X 7.5 miTL particle size: 17 urn) (SLIPELCO), a 
column for separation of water soluble polymers and oligosaccharides. TAP fractions 
�� 
were eliited using 0.5 M NaCl at a flow rate 0,5 ml/ip.in at 25 Dextran standards of 
molecular weight 25, 80, 270 and 650 kDa respectively were used rbr deteimining the 
TTiolecular weight o f polysaccharide in sample. 
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3,2 In Vitro Studies 
3.2.1 Maintenance of Cell Lines 
Unless otherwise stated, all the reagents and culture media used in this section 
were purchased from GiBCOBRL. Four cancer cell lines were used; two of them were 
human leukemia cell lines, HL-60 and K-562. Human liver cancer cell line，HepG2 as 
well as human beast cancer cell line, MCF-7 were also used. Cultures were maintained 
in RPMI1640 medium (Sigma) supplemented with 10% heat-activated (56�C，60 min) 
fetal bovine serum in the presence of 1% penicillin (10,000 u/ml)，1% streptomycin 
(10,000 ^g/ml) and 0.1 % amphotericin B (250 ^ig/ml). The monkey kidney cell line, 
Vero cell used in toxicity test was grown in minimal essential medium (MEM) with 
IQo/o heat-inactivated fetal bovine serum in the presence of 20 mM Hepes，2 mM of 
glutamine and 0.6% of gentamycin (4 mg/ml). All cell lines were maintained in 37 T 
incubator with 5% CO2 at 95% humidity. 
3.2.2 Effect on Cancer Cell lines 
In order to determine whether TAP fractions possess any direct cytotoxicity 
towards cancer cells, fractions were incubated with the cell lines for 72 h. The effects 
of TAP on cell density were evaluated by Trypan blue exclusion method or MTT assay, 
depending on the cell line used. 
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3.2.2.1 Trypan Blue Exclusion Methods 
The effects of TAP fractions on suspension cancer cell lines, HL-60 and K-562 
were evaluated by Trypan blue exclusion method. In this test, the target cells were 
seeded at IxlO" cells/well in a 96-well U-shape tissue culture plate (Falcon)，incubated 
with TAP fractions (at a final concentration of 50, 100 and 200 ^lg/ml) for 72 h，at 37 
T , 5% CO2 and 95% humidity. Same volume of 0.4 % Trypan blue in 
phosphate-buffered saline (PBS) was added to each well after incubation. Trypan blue 
would stained death cells blue whereas viable cells would remain unstained. The 
number of cells in each well was counted with the aid of a hemocytometer. The 
percentage of inhibition was calculated by the following equation: 
r Avera2;e number of viable cells in the treatment group 
。 - — — X 100% 
� . Average number of viable cells in the control group 
3.2.2.2 MTT Assay (Mosmann, 1983) 
The effect of TAP fractions on the two adhesion cell lines HepG2 and MCF-7, 
were examined by MTT assay (Mosmann，1983). In a 96-well flat-bottom tissue 
culture plate (Falcon), the target cells were seeded at a density of 1x10) cells/ml of 0.2 
ml/well. TAP 1，2 and 3 at doses: 50, 100 and 200 [xg/ml were respectively incubated 
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with those cells at 3 7 � C , 5% CO2 and 95% humidity. After 72 h’ 20 of freshly 
prepared MTT (3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide, 
Sigma) (5 mg/ml) in sterile PBS was added to each well. The plates were further 
incubated at 3 7 � C for 5 h. Upon incubation, the pale yellow MTT would be converted 
to dark blue formazan compound by active mitochondrial dehydrogenase in viable 
cells. The amount of dark blue crystal produced is directly proportional to the viable 
cells present. Following incubation, the medium was discarded and 150 i^l of 0.04 N 
HCl in isopropanol was added to each well to solublize the dark blue crystal. The 
absorbance of each well was determined by a microplate reader (SPECTRAmax 250) 
at a wavelength of 570 nm with a reference wavelength of 690nm. The percentage of 
inhibition was calculated by the following equation: 
r Average absorbance in the treatment group ) 
1 • ： X 100% 
Average absorbance in the control group 
3.2.3 Effect on Normal Cell Line 
A monkey kidney cell line, Vero cell was used to determine the cytotoxicity of 
t a p fractions on normal cell. The changes in cell density of Vero cells were also 
evaluated by MTT assay. TAP fractions at a final concentration of 1 mg/ml were 
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incubated with Vero cell under the same condition as described in M T T assay. 
3.2.4 Coulter Counter 
In addition to Trypan blue exclusion method’ the change in cell density of HL-60 
cells was also examined with the aid of Coulter counter. HL-60 cells were seeded at a 
density of IxlO' cells/ml and 1 ml/well in a 24-well flat-bottom tissue culture plate 
(Falcon). TAP 2 at final concentrations of 50, 100 and 200 pig/ml were respectively 
incubated with the target cell for 72 h at 37。C, 5 % CO: and 95% humidity. In order to 
evaluate the number of cells by a coulter counter, 0.5 ml of the cell culture was diluted 
to 100 ml using azide free balanced electrolyte solution (ISOTON® 11) after 
incubation. The numbers of cells were counted by using Multisizer II System 
(COULTER) with an orifice diameter of 50 |im. Siphon mode was used as the control 
method and the analytical volume was 500 \x\. 
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3.3 In Vivo Studies 
3.3.1 Animals 
Male BALB/c mice (8-9 weeks) were used in this study. Throughout the 
experiment, all the animals were housed in the Animal House (Department of Biology, 
C U H K ) at temperature 21 ± 2 T , 12 h/12 h light/dark cycle. They were freely access 
to tap water and standard rodent chow. All the mice were acclimatized for at least a 
week before any experiment started. 
3.3.2 Maintenance of Sarcoma 180 Cell Line 
Sarcoma 180 cell line was maintained in male BALB/c mouse peritoneum before 
transplanted into the back of the mouse. Sarcoma 180 cells (5x10^ cells/ 0.2 ml) were 
injected intraperitoneally and maintained in the mouse peritoneum for seven days. On 
�� 
the seventh day, the mouse was killed by cervical dislocation. The ascitic fluid 
containing Sarcoma 180 cells was collected by lavage of peritoneal cavity with sterile 
PBS extensively. The Sarcoma 180 cells were washed three times with 0.45% PBS 
(sterile) and resuspended in sterile PBS again. The number of viable cells was 
determined by Trypan blue exclusion method. After that, the cell suspension was 
diluted to 2.5x10' cells/ml by sterile PBS. Finally, 0.2 ml of Sarcoma 180 cell 
suspension of was either passed to another mouse by intraperitoneal injection or 
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transplanted subcutaneously into the back of mice for studying the effect of TAP 
fractions on Sarcoma 180 solid tumor in vivo. 
3.3.3 Effect of TAP Fractions on Sarcoma 180 Solid Tumor 
In order to study the antitumor effect of TAP fractions /" vivo, male BALB/c mice 
(8-9 weeks) were used. At the beginning of the experiment, suspension of Sarcoma 
180 cells was prepared according to Section 3.3.2. Then, each mouse was 
anaesthetized by diethyl ether and 0.2 ml of5xlO^ Sarcoma cells were subcutaneously 
transplanted into the back of the mouse. Intraperitoneal (i.p.) injections of TAP 
fractions were done either 24 h or 72 h after transplantation. 
3.3.3.1 Injection of TAP Fractions 24 h after Transplantation 
Exactly 24 h after transplantation, the tumor-bearing mice were divided into 
groups and caged separately. TAP 1，2 and 3 in sterile PBS (each fraction at three 
different doses: 0.25, 1 and 4 mg/kg) were i.p. injected into separated groups of mice 
respectively for 10 consecutive days. Crude TAP in sterile PBS of dose 20 mg/kg was 
used as reference. The mice of the control group would receive sterile PBS only. Nine 
days later, the mice were killed by cervical dislocation (Fig. 3.3a). The body weight of 
each mouse was recorded before the tumor of each mouse was enucleated and weighed. 
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The percentage change in body weight and tumor inhibition ratio was calculated by the 
following equations respectively: 
Percentas^ e f Average (body weight - tumor weight) of treatment group ) 
. h d = 1- — xlOO% 
nge in Doay Average (body weight - tumor weight) of control group 
weight L 
Tumor C Average tumor weight of treatment group ^ 
inhibition = 1 — X 100% 
Average tumor weight of control group 
ratio L J 
3.3.3.2 Injection of TAP Fractions 72 h after Transplantation 
Each tumor-bearing mouse was examined carefully by hand 72 h after 
transplantation. Only those mice developed solid tumor were used and divided into 
groups. Intraperitoneal injection of TAP fractions would follow the same dose and 
scheduled as described in Section 3.3.3.1. (Fig. 3.3b). The percentage change in body 
weight and tumor inhibition ratio were calculated using the same equations as 
described in Section 3.3.3.1. 
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Day 0 1 10 
Tumor i.p. injection of Experiment 
transplantation TAP fractions ended 




Day 0 3 12 21 
Tumor i.p. injection of Experiment 
transplantation TAP fractions ended 




Fig. 3.3 Time schedule of in vivo study, (a) Injection of TAP fraction 24 h after tumor 
transplantation, (b) Injection of TAP fractions 72 h after tumor 
transplantation. 
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3.4 Effect of TAP Fractions on Modulating mRNA Expression of Cytokines and 
Nitric Oxide Synthase 
3.4.1 Treatment of Mice 
Male BALB/c mice of age 8-9 weeks were used in this experiment. They were 
divided into two groups. One of the groups received 4 mg/kg TAP in sterile PBS by 
intraperitoneal injection for 5 consecutive days and the control group received sterile 
PBS only. The splenocytes and peritoneal exudate cells were isolated 24 h after 
injection completed. 
3.4.2 Isolation of Splenocytes and Peritoneal Exudate Cells 
Peritoneal exudate cells (PEC) were obtained by lavage of mouse peritoneum 
with ice-cold sterile Hank's balanced salt solution (HBSS, Sigma). The lavage fluid 
�� 
obtained was centrifliged at 400 g，4。C for 10 min using Beckman Allegra 6R low 
speed centrifuge. The cell pellet obtained was washed with 10 mlHBSS again. On the 
other hand, the spleen of each mouse was also dissected out，washed with sterile HBSS 
and transferred to a new 50 ml Falcon tube. PEC and spleen obtained were subjected to 
R N A extraction immediately. 
- 5 1 -
Materials & Methods 
3.4.3 Extraction of Total R N A from Splenocytes and Peritoneal Exudates Cells 
R N A extraction was performed using TriPure'^ ^^  Isolation Reagent (Boehringer 
Mannhem) according to the protocol provided with some modifications. To each 
sample, either PEC or the spleen, 10 ml of TriPure reagent was added. The samples 
were homogenized and incubated at room temperature for 5 min. Then, 2 ml of 
chloroform was added to each homogenized sample. After thorough mixing，the 
mixture was incubated at room temperature for 15 min and subjected to centrifugation 
(Centrifuge 581 OR, E P P E N D O R F ) at 18,514 g, 4。C for 20 min. After centrifugation, 
the total R N A , D N A and protein in the sample were separated into three phases 
respectively. The uppermost colorless phase containing total R N A in sample was 
transferred to a new 50 ml Falcon tube. The content was mixed with 5 ml isopropanol 
following 10 min incubation at room temperature. 
�� 
R N A pellet form each sample would be obtained by centrifugation at 18,514 g，4 
for 20 min. The supernatant was discarded and the pellet was washed by 75% 
ice-cold ethanol. The pellets were dried under vacuum and resuspended in 50-100 [il 
diethyl pyrocarbonate (DEPC) (Sigma) treated water. BioPhotometer (EPPENDORF) 
was used to determine the R N A concentration of each sample. 
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3.4.4 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
RT-PCR was performed according to Liu et al (1996a) and Liu (1999). The 
following reagents were used in reverse transcription; 40 u/|il RNase inhibitor and 10 
m M of dNTPs mix (Promega); 0.1 |ig/|il oligo dTi2-i8(Pharmacia); 100 m M 
dithiothreitol (DTT, GibCOBRL), 200 ii/|il Moloney murine leukemia virus ( M M L V ) 
reverse transcriptase (GibCOBRL) and 5X M M L V reverse transcriptase reaction 
buffer (GibCOBRL). Primers of cytokines and nitric oxide synthase used in 
polymerase chain reaction (PGR) were kindly provided by Dr. M.C.Fung (Department 
of Biology，CUHK). Primer sequences were detailed in Table 3.1. P G R was performed 
with the aid of the following reagents purchased from Promega: 10 m M of each dNTPs, 
25 m M of MgCl2, Taq D N A polymerase (5 u/jil) and thermophilic D N A polymerase 
lOX reaction buffer (MgCl^-free). 
3.4.4.1 Reverse Transcription 
R N A sample was diluted to 0.1 |ig/|il by D E P C (Sigma) treated water. Ten 
microliter of the sample was heated at 65。C for 5 min and chilled on ice immediately. 
Then, equal volume of reaction mixture (to a final concentration of 40 u RNase 
inhibitor, 0.1 jig oligo dT^-is, 0.5 m M of each dNTPs, IX M M L V reverse 
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Table 3.1 Sequences of primers used in PGR 
Cytokines/NOS Sequence (5，to 3，） Size (bp) 
IL-1 a upper primer ACAGTATCAGCAACGTCAAGCAA 
546 
lower primer CCGACTTTGTTCTTTGGTGGCA 
IL-1 p upper primer GAGCTTCAGGCAGGCAGTATC 
382 
lower primer GTATAGATTCTTTCCTTTGAGGC 
IL-2 upper primer TTGATGGACCTACAGGAGCTCCTGAGCA 
393 
lower primer AGAGAGCCTTATGTGTTGTAAGCAGGAGG 
IL-12 p35 upper primer TGCCAGGTGTCTTAGCCAGTC 
477 
lower primer ATTTTCACTCTGTAAGGGTCTGC 
IL-12 p40 upper primer CAGCTTCTTCATCAGGGACAT 
361 
lower primer TTTCCTTTCCAACGTTGCATCCT 
IFN-Y upper primer A G G A A C T G G C A A A A G G A T G G T G 
353 
lower primer GTGCTGGCAGAATTATTCTTATTG 
‘ 
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Table 3.1 Sequences of primers used in P C R (continued) 
Cytokines/ NOS/ GAPDH Sequence (5，to 3，） Size (bp) 
TNF-a upper primer TCCCCAAAGGGATGAGAAGTTC ^^^ 
lower primer TCATACCAGGGTTTGAGCTCAG 
TGF-P upper primer CATGGAGCTGGTGAAACGGAAGCGCATC ^^^ 
lower primer CTCCAGTGACGTCAAAAGACAGCCACTC 
GM-CSF upper primer TGGTCTACAGCCTCTCAGCAC ^^^ 
lower primer AAGGGGATATCAGTCAGAAAGGT 
M-CSF upper primer GTAGCCACATGATTGGGAATGG ^^^ 
lower primer TCATGGAAAGTTCGGACACAGG 
�� 
SCF upper primer CGAAGAGGCCAGAAACTAGATC 
533 
lower primer GGGAATTTGTTTAAGGCTGCTTC 
NOS upper primer CCGGCAAACCCAAGGTCTAC 
354 
lower primer CTCACCATTATCTTTACTCAGTG 
- 5 5 -
Unierials & Methods 
transcriptase reaction buffer, 10 m M D T T and 200 u Moloney murine leukemia virus 
transcriptase) was added to the sample and incubated at 37 T for exactly 1 h. The 
reaction mixture was diluted 5-fold by DEPC-treated H2O. 
3.4.4.2 Polymerase Chain Reaction 
The diluted c D N A (10 |il) was boiled for 10 min and chilled on ice immediately 
for 2 min. P G R cocktail (40 jil) was added to the c D N A (containing a final 
concentration of 0.2 m M of each dNTPs, 1.5 m M ofMgCli, lu Taq D N A polymerase, 
IX thermophilic D N A polymerase reaction buffer, 50 pmole of each of the upstream 
and downstream primers). The reaction mixture was incubated at 94 T for 5 min, 30 
P G R cycles of 94。C for 1 min, 56。C for 1 min and 72。C for 1 min were performed 
using Peltier Thermal Cycler (MJ Research). Finally，the reaction mixture was 
incubated at 72 X for 7 min to ensure the reaction was completed. 
The P G R products obtained were examined by electrophoresis using 1% agarose 
in IX TBE (Tris-Borate-EDTA) buffer stained with ethidium bromide. Then，PGR 
products were visualized by Fluorescent Gel Doc PC system (BIO-RAD). The relative 
amounts of m R N A between samples were compared by the intensity of bands. The 
m R N A of a cytokine or N O S would consider as down- or up-regulated if there were 
more than two fold difference between the intensity of band of control and treatment 
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mice. A housekeeping gene, G A P D H (Glyceraldehyde-3-phosphate dehydrogenase) 
gene was used as a standard to normalize R N A samples. 
3.4.5 D N A Sequencing 
RT-PCR products of m R N A samples using primers of IL-lp, TNF-a and N O S 
respectively were purified by QIAquick P G R Purification Kit 250 (QIAGEN). The 
quantities of purified D N A templates were measured by BioPhotometer 
(EPPENDORF) before diluted to 0.1 |ig/|il. Cycle sequencing reactions were 
performed by using dRhodamine terminator cycle sequencing ready reaction kit (ABI 
PRRISM, Applied Biosystem). P G R tubes with 10 |il reaction mixture of each target 
gene (IL-lp, TNP-a or N O S ) containing 0.4 |ig D N A template, 4 \xl terminator 
reaction mix and 1.6 pmole primer of target gene were prepared. Sequencing reactions 
� - � 
were carried out as follow: 25 cycles of 94。C, 10 sec; 56。C, 5 sec and 72。C, 4 min. 
After reaction complete，the entire content in each P G R tube was then transferred 
to a 1.5 ml tube containing 1 [x\ of sodium acetate (3 M , pH 5.2) and 25 |il of ethanol 
(95%). The tubes were left in-20。。freezer overnight. The sequenced products were 
spin down by centrifligation at 14,000 rpm for 30 min using Centrifuge 581 OR 
(EPPENDORF). The supernatant was discarded and the pellets were washed with 200 
jj.1 75% ethanol. Finally, the pellets were dried under vacuum. 
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The dried pellets were dissolved in 12 ml TSR (Template Suppression Reagent, 
ABI) and denatured at 95 ^ C for 2 min. The sequence of each sample was analyzed by 
Genetic Analyzer (ABI PRISM 310). The results of sequences were compared to those 
found from the database established by the National Center for Biotechnology 
Information (NCBI) in U S A via its homepage: 
http://www.ncbi.nlin.nih.gov/blast/Blast.cgi. 
3.5 Statistical Analysis 
Results were expressed in mean 士 standard deviation (S.D.) and analyzed by 
Student's t-test. The level of significance was taken at p<0.05. 




4.1 Isolation and characterization of TAP fractions 
4.1.1 Percentage Yield of TAP Fractions 
Following hot water extraction and ethanol precipitation, 48.0 g crude TAP was 
obtained (Table 4.1a) out of 204 g dried form of Tremella aurantialba. Nearly a 
quarter of raw materials contained this crude polysaccharide. Application of 50 mg 
TAP to anion exchange chromatography (Fig. 4.1) resulted in three fractions, TAP 1, 
2 and 3. Percentage yield of TAP 3 was the highest while TAP 1 and 2 were much 
lower (Table 4.1b). 
4.1.2 Polysaccharide and Protein Content of TAP Fractions 
Each milligram of crude TAP contained 0.78 mg polysaccharide as detected by 
-59-
Results 
phenol sulfuric assay (Dubois et al.，1956; Harris et al.，1995) and 0.04 m g of 
protein as detected by Lowry method (Lowry et al., 1951; Waterborg & Matthews, 
1994). Among the three fractions, TAP 3 contained the highest amount of 
polysaccharide (0.92 mg per m g of sample) and TAP 2 had the highest percentage of 
protein (0.15 m g per m g of sample) (Table 4.2). 
4.1.3 Relative Monsaccharide Contents in TAP Fractions 
The relative monosaccharide contents in the three TAP fractions were listed in 
Table 4.3. Glucose, galactose, mannose, xylose, arabinose and flicose were detected 
in TAP 1. Among them, glucose constitutes the highest proportion (19.76%). 
Mannose, xylose, glucose and galactose were detected in TAP 2, whereas trace 
amount of rhamnose, flicose, arabinose were also detected in this fraction. On the 
other hand, TAP 3 consists of polysaccharide composed of mannose and xylose 
only. 
The result of modified carbazoie assay (Table 4.4) showed that the uronic acid 
content is highest in TAP 3 (0.23 m g per m g of TAP 3). 
4.1.4 Result ofHPLC 
HPLC elution pattern of the three fractions was shown in Fig 4.2 a, b and c. 
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Unfortunately, the size of components in all three fractions did not fall between the 
range of molecular weight marker used (25-670 kDa) (Fig.4.3). TAP 1 contained 
two peaks, having molecular weight lower than 25 kDa and larger than 670 kDa 
respectively. TAP 2 contained three peaks with two peaks that were very close to 
each other; they had molecular weight larger than 670 kDa and smaller than 25 kDa 
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Fig. 4.1 Anion exchange chromatography of TAP on a DEAE-cellulose column. 
�� 
50 mg of sample was applied to a 1.8 x 20 cm DEAE-cellulose anion exchange 
column. The flow rate was 30 ml/h and the fractionation was collected at 6 ml/tube. 
The presence of polysaccharides was determined by phenol-siilfuric assay at 490nm. 
Elution of distilled water 0.04 M and 0.1 MNaCl solutions obtained three fractions 
and designated as TAP I, 2 and 3 respectively. 
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Table. 4.1 (a) Percentage yield of crude TAP isolated from 204 g of dried Tremella 
aurantialba. 
Product Color Weight (g) Vield (%) 
TAP Pale yellow 48.0 23.5 
社％ yield 二 (total weight of crude TAP obtained/ total weight of dried Tremella aurantialba 
used) X 100%. -
Table. 4.1 (b) Percentage yields of TAP fractions isolated from 50 mg of crude TAP. 
Products Color Weight (mg) Yield (%) 
、- TAP 1 Yellow 1.85 3.70 
TAP 2 White 1.17 2.34 
TAP 3 White 25.39 50.8 
yield 二 (weight of each TAP fraction obtained / 50 mg of crude TAP) x 100%. 
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Table. 4.2 Polysaccharide and protein content in TAP fractions. 
m g of polysaccharide in 1 m g m g of protein in 1 m g of 
Products 
of product product 
Crude TAP 0.78 ± 0.02 0.04 ± 0.00 
TAP 1 0.21士 0.01 0.10 士 0.02 
TAP 2 0.81 ±0.01 0.15 ±0.01 
TAP 3 0.92 ± 0.01 0.02 ± 0.00 
The polysaccharide and protein content in crude TAP and TAP fractions were determined by 
� phenol-sulfuric assay and Lowry-Folin method respectively. 
The results were expressed in average weight of mg of polysaccharide (or mg of protein) in 
1 mg of sample 士 S.D. 
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Table 4.3 Relative percentages of monosaccharides (% w / w) in TAP fractions 
determined by Gas Chromatography. 
Relative Percentage (% w / w) 
Monosaccharides — - - “ 
TAP TAP 1 TAP 2 TAP 3 
Fucose T 1.14 T N.D. 
Galactose 丁 4.01 3.20 N.D. 
Glucose 2.59 19.8 6.53 N.D. 
Mannose 35.9 7.66 23.0 23.4 
Xylose 16.9 1.88 8.43 11.2 
� Arabinose 丁 1-41 丁 N.D. 
Ribose N.D. N.D. N.D. N.D. 
Rhamnose T N.D. T N.D.  
"T" indicates trace amount of monosaccharide detected. 
''N.D. ” indicates the particular monosaccharide was not detectable. 
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Table. 4.4 Uronic acid content in TAP fractions. 
Products m g of uronic acid in 1 m g of product 
Crude TAP 0.27 ±0.03 
tap 1 0.05 士 0.01 
TAP 2 0.15 ±0.01 
TAP 3 0.23 ±0.01 
The uronic acid content in crude TAP and TAP fractions were determined by modified 
�- carbazole assay. 
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Fig 4.3 Determination of molecular weight of TAP fractions by HPLC using dextran 
standard of weight 25, 80, 270 and 650 kDa respectively. 
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4.2 Effects of TAP Fractions In Vitro 
4.2.1 Effects of TAP Fractions on Suspension Cancer Cell Lines 
The effect of TAP fractions on suspension cancer cell lines, HL-60 and K-562 
were analyzed by Trypan blue exclusion method />? vitro. Among the three fractions, 
TAP 2 could significantly inhibit the growth of HL-60 cells in a dose-dependent 
manner. At a dose of 200 |ig/ml, TAP 2 could inhibit the cell growth by 44%. 
However, TAP 3 enhanced the HL-60 proliferation by 12% at a dose of 100 jig/ml 
(Fig. 4.4). All the three fractions could neither promote nor inhibit the growth of 
K-562 (Fig. 4.5). The viability of HL-60 and K-562 were both over 99%. The results 
were expressed in mean cell density (10^ cells/ml) 士 S.D. 
4.2.2 Effects of TAP Fractions on Adhesion Cancer Cell Lines 
The effects of TAP fractions on MCF-7 and HepG2 were evaluated by M T T 
assay. The results showed that TAP 2 could inhibit the growth of MCF-7 and HepG2 
in a dose-dependent manner. At dose 200 |ig/ml, TAP 2 could inhibit the growth of 
MCF-7 and HepG2 by 20% and 33% respectively (Fig. 4.6 and 4.7). TAP 1 could 
inhibit the growth of the two cell lines at low dose (50 |ig/ml). On the other hand, 
TAP 3 could significantly increase the growth of MCF-7 by 9 % at high dose. The 
results were expressed in mean absorbance 570nm 土 S.D with a reference 
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wavelength of 690nm. 
4.2.3 Effects of TAP Fractions on Normal Cell Line 
The cytotoxicity of TAP fractions were evaluated by a normal monkey kidney 
cell line, Vero cell using M T T assay. At 1 mg/ml, the three TAP fractions did not 
show any significant toxicity towards the normal cell line (Fig. 4.8). The results 
were expressed in mean absorbance 570nm 士 S.D with a reference wavelength of 
690nm. 
4 2.4 Effect of TAP 2 on HL-60 Cell Line as Evaluated by Coulter Counter 
The effect of TAP 2 on HL-60 was also determined by Coulter counter. TAP 2 
at final concentrations of 50, 100 and 200 |ig/ml were respectively incubated with 
HL-60 cells for 72 h at 37 5 % CO: and 95% humidity. After 72 h incubation, 0.5 
ml of the cell culture was diluted and counted by using Multisizer II System 
(COULTER). The result showed that TAP 2 could significantly decrease the cell 
density as dose increased (Fig. 4.9). The results were expressed in mean cell density 
(10^ cells/ml) 士 S.D. TAP 2 can inhibit the growth of HL-60 cells by 27% at dose 




Concentration Inhibition ratio (%) 
Oig/ml) TAP1 TAP 2 TAP 3 
50 -4.59 -3.42 +6.62 
100 -10.2 -21.5 +12.4 
200 -4.59 -43.7 +0.51 
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Fig 4.4 Effects of TAP fractions on HL-60 cell line after 72 h incubation. 
梓Table indicates the percentage of inhibition on HL-60 cell growth caused by the three 
TAP fractions respectively. 
TAP fractions at dose 50,100 and 200 fig/ml were incubated with HL-60 cells for 72 
h. The effect of TAP fractions were evaluated by Trypan blue exclusion method. 
The results were expressed in mean cell density (10^ cells/ml) ± S.D. Values that 
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Concentration Inhibition ratio (%) 
(ng/ml) TAP1 TAP 2 TAP 3 
50 -5.46 +12.0 +9.14 
100 -1.91 +7.78 +9.41 
200 -5.46 +1.50 -5.73 
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Fig 4.5 Effects of TAP fractions on K-562 cell line after 72 h incubation. 
•Table indicates the percentage of inhibition on K-562 cell growth caused by the three 
TAP fractions respectively. 
TAP fractions at dose 50,100 and 200 /jg/ml were incubated with K-562 cells for 72 
h. The effect of TAP fractions were evaluated by Trypan blue exclusion method. 
The results were expressed in mean cell density (10^ cells/ml) ± S.D. Values that 




# Concentration inhibition ratio (%) 
(^ ig/ml) TAP 1 TAP 2 TAP 3 
50 -12.2 -5.51 +5.91 
100 -6.93 -16.2 +1.06 
200 +3.87 -19.8 +9.14 
1 . 0 0 � 
0.90 * 
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Fig 4.6 Effects of TAP fractions on MCF-7 cell line after 72 h incubation. 
杜Table indicates the percentage of inhibition on MCF-7 cell growth caused by the 
three TAP fractions respectively. 
TAP fractions at dose 50,100 and 200 呢/ml were incubated with MCF-7 cells for 
72 h. The effect ofTAP fractions were evaluated by MTT assay. 
The results were expressed in mean absorbance 570nm 士 S.D. with a reference 
wavelength of 690nm. Values that showed significant different from control were 
indicated by * atp<0.05 and ** atp<0.01 respectively. 
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# — ~ — — — = ~ 
Concentration Inhibition ratio (%) 
(^ ig/ml) TAP 1 TAP 2 TAP 3 
50 -15.7 -19.7 -7.88 
100 -12.9 -27.0 -15.9 
200 -14.2 -32.6 -9.45 
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1.20 J 
1.10 ** 」 
E 100 -、^r：：：：：：^^^^^ ^ 
§ 0.80 - 丄 ^； ^ ^ 1  
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Fig 4.7 Effects of TAP fractions on HepG2 cell line after 72 h incubation. 
林Table indicates the percentage of inhibition on HepG2 cell growth caused by the 
three TAP fractions respectively. 
TAP fractions at dose 50’ 100 and 200 jjg/ml were incubated with HepG2 cells for 
72 h. The effect of TAP fractions were evaluated by MTT assay. 
The results were expressed in mean absorbance 570nm 士 S.D. with a reference 
wavelength of 690nm. Values that showed significant different from control were 
indicated by * atp<0.05 and ** atp<0.01 respectively. 
-74-
Results 
0 . 7 � 
0.6 -
！ 。 霸 _ - • 
i— > C1 一 
-§ 0.3 
< 0.2 -
•• . . . . . . •• .，. 
.:‘..：... . .......： . . . . . . 
0.1 -
0——1—1——I——L——L_1——I—__—I————J——‘ 
Control TAP 1 TAP 2 TAP 3 
(1mg/ml) (Img/ml) (1mg/ml) 
Fig 4.8 Effect of TAP fractions on Vero cell after 72 h incubation. 
TAP fractions at dose I mg/ml were incubated with Vero cells for 72 k The effect of 
TAP fractions were evaluated by MTT assay. 
The results were expressed in mean absorbance 570nm ± S.D with a reference 
wavelength of 690nm, Values that showed significant different from control were 
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Fig 4.9 Effect of TAP 2 on HL-60 cell line after 72 h incubation determined by 
Coulter counter. 
TAP 2 at dose 50, 100 and 200 jug/ml were incubated with HL-60 cells for 72 h 
The effect of TAP 2 on HL-60 cell line was determined by Coulter counter after 
incubation. 
The results were expressed in mean cell density (l(f cells/ml) ± S.D. Values that 
are significantly different from control were indicated by ** atp<0.01. 
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Table. 4.5 Effect of TAP 2 on the cell diameters of HL-60 cells after 72 h incubation. 
Treatments Average cell diameter 士 S.D. Percentage change 
(^lm) (%) — 
Control 10.03 ± 0.078 -
TAP 2 (^ ig/ml) 50 10.17 士 0.037 *** 1 
100 10.19 ± 0.042 *** 2 
200 10.15 ± 0.038 ** 1 
� TAP 2 at dose 50, 100 and 200 jug/ml were incubated with HL-60 cells. The effect of TAP 2 
on HL-60 cell line was determined by Coulter counter. 
The results were expressed in mean cell diameter (pim) 土 S.D. Values that are significantly 
different with control were indicated by ^^^atp< 0,01 and *** atp< 0.005 respectively. 
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4.3 Antitumor Effect of TAP Fractions In Vivo 
The injection of TAP fractions did not affect the change of body weight in 
tumor -bearing mice when compared to the control group (Tables 4.6 and 4.7) except 
those received TAP 3 24 h after tumor transplantation at dose 0.25 mg/kg. 
All TAP 1, 2 and 3 could significantly inhibit the growth of Sarcoma 180 solid 
tumor. When TAP fractions were injected 24 h after tumor implantation, TAP 1 and 
2 could both inhibit the solid tumor growth in a dose dependent manner (Table 4.8). 
Among the three fractions, TAP 2 showed the highest antitumor activity in vivo at 
dose of 4 mg/kg. TAP 3 showed inhibition on Sarcoma 180 solid tumor at dose 
1 mg/kg only (Table 4.8). 
Besides, when TAP fractions were injected 72 h after tumor transplantation, the 
inhibition pattern of the three fractions on tumor were similar (Table 4.9). TAP 2 
still showed the highest inhibition at dose 4 mg/kg. TAP 3 at a lower dose could 
inhibit the growth of solid tumor and the inhibition ratio was highest at dose 1 
mg/kg (Table 4.9). 
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Table 4.6 Effect of TAP fractions on body weight of tumor-bearing mice which 
received i.p. injection 24 h after tumor transplantation. 
##Average Body Weight (g) 士 S.D. •Percentage change 
"Treatments   
Initial (I) Final (F) in Body Weight (%) 
Control (PBS) 25.8±0.62 26.0±1.13 +1 
TAP 20mg/kg 25.5 土 1.27 26.6 士 0.87 +4 
TAP 1 0.25mg/kg 22.6 土 0.74 24.1 士 0.69 +6 
Img/kg 2 4 . 5 士 0 . 7 6 2 4 . 8 ± 0 . 7 7 + 1 
4mg/kg 24.6 士 1.70 25.0 士 2.22 +2 
TAP 2 0.25mg/kg 23.4 士 1.35 24.8 ± 1.18 +6 
Img/kg 23.3 土 0.69 24.5 ±0.71 +5 
4mg/kg 23.9 土 1.88 24.5 ± 1.24 +2 
TAP 3 0.25mg/kg 24.6 士 0.99 26.3 土 1.17 +7* 
Img/kg 2 4 . 5 士 1 . 9 7 2 5 . 1 ± 2 . 8 2 + 3 
、 4mg/kg 24.9 士 1.10 25.5 土 1.22 +2 
社Sarcoma 180 cells (5 x l(f cells/0.2 ml) were subcutaneously injected into the back of 
male BALB/c mice. 24 h later, PBS or TAP fractions were i.p. injected into the 
tumor-bearing mice of control and treatment groups respectively for 10 consecutive days. 
•The body weight was recorded on the date of tumor inoculation (I) and the date 
experiment end (F). 
•The change in body weight = [(F-tumor weight)-!]/I x 100%. 
The results were expressed in mean body weight (g) 士S.D. The change in body weight in 




Table 4.7 Effect of TAP fractions on body weight of tumor-bearing mice which 
received i.p. injection 72 h after tumor transplantation. 
##Average Body Weight (g) 士 S.D. ###Percentage change 
^Treatments  
Initial (I) Final (F) in Body Weight (%) 
Control 25.2 土 1.20 26.6 士 0.91 +5 
TAP 20mg/kg 24.5 ±2.61 25.1 士 1.64 +3 
TAP 1 0.25mg/kg 25.2 士 1.37 26.1 士 1.20 +4 
1 mg/kg 2 3 . 8 士 1 . 3 7 2 5 . 2 ± 0 . 7 8 + 6 
4mg/kg 24.0 士 1.50 25.3 ±0.55 +6 
TAP 2 0.25mg/kg 24.6 士 1.78 25.8 士 1.48 +5 
1 mg/kg 24.8 土 1.15 . 25.7 士 1.28 +4 
4mg/kg 24.8 士 1.94 26.3 士 1.66 +6 
TAP 3 0.25mg/kg 23.9+1.23 25.4 士 1.54 +1 
1 mg/kg 24.7 士 1,24 26.4 ±0.75 +7 
、 4mg/kg 24.8 ±1.94 26.2 ±0.96 +6 
社Sarcoma 180 cells (5 x l(f cells/0.2 ml) were subcutaneously injected into the back of 
male BALB/c mice. 72 h later, PBS or TAP fractions were i.p. injected into the 
tumor-bearing mice of control and treatment groups respectively for 10 consecutive days. 
甜The body weight was recorded on the date of tumor inoculation (I) and the date 
experiment end (F). 
•The change in body weight = [(F-tiimor weight)-I]/I x 100% 
The results were expressed in mean body weight (g) 土S.D. The change in body weight in 




Table 4.8 Effect of TAP fractions on Sarcoma 180 solid tumor (i.p. injection 24 h 
after tumor transplantation). 
縣Average Tumor Weight (g) ###Inhibition ratio 
^Treatments n 
土 S.D. (%) 
Control 6 0.45 士 0.12 -
TAP 20mg/kg 6 0.22 士 0.05** -51.4 
TAP 1 0.25mg/kg 5 0.42 士 0.26 -6.24 
1 mg/kg 6 0.27 ±0.13* -40.0 
4mg/kg 6 0.28 士 0.10* -36.7 
TAP 2 0.25mg/kg 5 0.43 士 0.07 -3.79 
1 mg/kg 6 - 0 . 2 4 ± 0 . 1 3 * - 4 7 . 2 
4mg/kg 6 0.23 士 0.11** -49.9 
TAP 3 0.25mg/kg 6 0J9 士 0.25 -14.3 
1 mg/kg 5 0.26 ±0.10* -43.0 
、 4mg/kg 5 0.39 士 0.26 -12.2 
^Sarcoma 180 cells (5 x l(f cells/O.l ml) were subcutaneousfy injected into the back of 
male BALB/c mice. 24 h later, PBS or TAP fractions were i.p. injected into the 
tumor-bearing mice of control and treatment groups respectively for 10 consecutive days. 
甜The solid tumor were enucleated and weighed 9 days after the injection. 
•The inhibition ratio = (Average tumor weight of treatment - control)/controlx 100% 
The results were expressed in mean tumor weight (g) 土 S.D. Values that are significantly 




Table 4.9 Effect of TAP fractions on Sarcoma 180 solid tumor (i.p. injection 72 h 
after tumor transplantation). 
##Average Tumor Weight (g) ###Inhibition ratio 
#Treatments n 
士 S.D. (%) 
Control 6 0.74 土 0.38 -
TAP 20mg/kg 6 0.26 ±0.21* -64.9 
T A P l 0.25mg/kg 6 0.31 ±0.09* -58.7 
1 mg/kg 6 0.24 土 0.14* -68.0 
4mg/kg 6 0.28 ±0.15* -62.1 
TAP 2 0.25mg/kg 6 0.40 ± 0.27 -46.1 
1 mg/kg 6 ‘ 0.28 ±0.12* -62.1 
4mg/kg 6 0.20 士 0.15* -73.3 
TAP 3 0.25mg/kg 6 0.40 土 O.U* -54.4 
1 mg/kg 6 0 . 2 5 ± 0 . 1 3 * - 6 6 . 3 
、- 4mg/kg 6 0.36 ±0.27 -51.7 
抹Sarcoma 180 cells (5 x l(f cells/0.2 ml) were suhcutaneously injected into the back of 
male BALB/c mice. 72 h later, PBS or TAP fractions were i.p. injected into the 
tumor-bearing mice of control and treatment groups respectively for 10 consecutive days. 
•The solid tumor were enucleated and weighed 9 days after the J(f injection. 
猶 The inhibition ratio 二（Average tumor weight of treatment - control)/control x 100% 
The results were expressed in mean tumor weight (g) 土 S.D. Values that are significantly 




4.4 Effect of TAP Fractions on Modulating mRNA Expressions of Cytokines 
and Nitric Oxide Synthase (NOS) 
4 .4 .1 Results of RT-PCR 
Among the 12 genes being tested, IL-2, IFN-y and GM-CSF were not detected 
in either peritoneal exudate cells (PEC) or splenocytes of control and treated mice. 
IL-1 (3, IL-12 p35, IL-12 p40, TNF-a and TGF-P were upregulated in splenocytes of 
TAP 2-treated mice (Table 4.10). The expression level of IL-1 a and M-CSF of 
treated mice was more or less the same among the splenocytes of TAP 2-treated and 
the control mice. The m R N A expression level of N O S was not detected in the 
control or treatment mice (Fig 4.10). 
In PEC of TAP 2-treated mice, the m R N A expression levels of cytokine genes 
、- IL-1 a and TGF-P were down-regulated (Table 4.10). Only IL-1 (3 and TNF-a were 
upregulated in the PEC of treatment mice (Table 4.10). The expression levels of 
IL-12 p35 and M-CSF were the same in both the control and treated mice (Table 
4.10). However, IL-12 p40 and SCF were not detected in PEC of both groups of 




The RT-PCR products of IL-1 p，TNF-a and N O S were checked by sequencing 
to determine whether the gene transcribed were the target genes. Fig. 4.12, 4.13 and 
4.14 showed the results of sequencing and first ten sequences producing significant 
alignments for each target gene. The percentage of similarities between the genes 
sequenced and the target genes were not less than 94%. 
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Fig.4.10 mRNAs expression level of cytokines, NOS and GAPDH from splenocytes 
of TAP 2-treated mice compared with control. 
PBS or TAP 2 (4 mg/kg) were i.p. injected into control or treatment groups of male 
BALB/c mice respectively for 5 consecutive days. Splenocytes were isolated 24 h 
after the injection. (Lane M- lOObp DNA ladder. Lam T-from treatment group 
and Lane C- from control). 
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Fig.4.11 mRNAs expression level of cytokines, NOS and GAPDH from peritoneal 
exudate cells of TAP 2-treated mice conq>ared with control. 
PBS or TAP 2 (4 mg/kg) were Ip. injected into control or treatment groups of male 
BALB/c mice respectively for 5 consecutive days. Peritoneal exudate cells were 
isolated 24 h after the 5*奴 injection. (Lane M- lOObp DNA ladder, Lane T-from 
treatment group and Lane C- from control). 
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Table 4.10 Relative m R N A expression level ratio of cytokines and N O S in 
splenocytes and peritoneal exudate cells of TAP 2-treated mice. 
^Relative mRNA expression level ratio 
Cytokines/NOS  
Splenocytes PEC 
GAPDH 1.16 ±0.10 1.04 ±0.02 
IL-1 a 1.57 ±0.34 0.50 ±0.00 
IL-1 p 2.95 ±0.83 2.93 ±0.83 
IL-2 - -
IL-12p35 3.43 ±0-59 1.33 ±0.28 
IL-12 p40 Induced expression -
IFN-y -
TNF-a 3.30 ±0.92 4.01 ±1.97 
TGF-P 2.20 土 0.06 0.49 土 0.02 
GM-CSF - -
M-CSF 0.87 ±0.22 1.15 ±0.52 
SCF 0.90 ±0.25 -
NOS - Induced expression 
The mRNA expression level of cytokines or NOS were determined by measuring the intensity 
of visible bands using densitometer. 
社Relative mRNA expression level ratio = (intensity of cytokines or NOS in treatment group / 
intensity of cytokines or NOS in control group) 
For each cytokine or NOS, 2-3 electrophoresis were performed. The results were expressed 
in mean relative mRNA expression level ratio土 S.D. Values that are higher than 2 or lower 
than 0.5 would be considered as upregulated or down regulated respectively. 
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丨198293kbiMl5131.1IMUSILIBA Mouse interleukin 1-beta (IL-l-beta) mRNA, complete cds 
Length = 1339 ’ 
Score = 490 bits (247), Expect = e-136 
Identities = 313/325 (96%), Gaps = 8/325 (2%) 
Strand = Plus / Plus 
Query: 48 tctttcccgttggaccgtccaggatgaggacatgagcaccttctnttccttcatctttga 107 
丨丨mmi m m i m m m m m m m i i m I I M I I M I I I M M 
Sbjct: 312 tctttcccg-tggaccttccaggatgaggacatgagcaccttcttttccttcatctttga 370 
Query: 108 agaaga-nccatcctctgtgactcatagggatgatgatgataacctgctggtgtgtgacg 166 
m m i M M I I M I I I I I I I M IIIIIIIMIIIIMIIIIIIIIIIIIMIIII 
Sbjct: 371 agaagagcccatcctctgtgactcat-gggatgatgatgataacctgctggtgtgtgacg 429 
Query: 167 tccccattnagacagctgcactacaggctccgagatgaacaacaaaaaagcctcgtgctc 226 
I m m I I I I I I I I I I I M I M I I I I I I I I I I I I M I I I I I I I I M M I I I I I I I I 
Sbjct: 430 ttcccatt-agacagctgcactacaggctccgagatgaacaacaaaaaagcctcgtgct- 487 
Query: 227 gtcggacccatatgagctgaaagctctccacctcaatggacagaatatcaaccaacaagt 286 
I I I I I M M M I M i l l l l l l l M I I I I I I I I I I I I I I I I I I I I I M I I I i l l l l l l M I 
、- Sbj ct: 488 gtcggacccatatgagctgaaagctctccacctcaatggacagaatatcaaccaacaagt 547 
‘ # 
Query: 287 gatattctccatgagctttgtacaaggagaaccaagcaacgacaa^ataccttgtgggcc 346 
i m m m m i m m m m m m m m m i M i m m 丨丨丨 ii i i 
Sbjct: 548 gatattctccatgagctttgtacaaggagaaccaagcaacgacaaaatacc-tgt-ggcc 605 
Query: 347 ttggggcctcaaaggaaagaatcta 371 
II M I I I M M I I I I I I I I M I I I 
Sbjct: 606 11-gggcctcaaaggaaagaatcta 629 
Fig. 4.12 Results of sequencing for IL-1 p. 
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〉gi173055841 refINM 013693.11 Mus musculus tumor necrosis factor (Tnf), mRNA 
Length = 1619 
Score = 603 bits (304)， Expect = e-170 
Identities = 347/355 (97%), Gaps 二 5/355 (1%) 
Strand = Plus / Plus 
Query: 10 atcatttctatggcccana-catcacactcagatcatcttctcaaaattcgagtgacaag 68 
1111 i i i i i i i i M M 丨丨 m m m m m i m m m m m i m m 
Sbjct: 367 atcagttctatggcccagaccctcacactcagatcatcttctcaaaattcgagtgacaag 426 
Query: 69 cctgtagcccacgtcgtagcaaaccaccaagtggnaggagcagctggagtggctgagcca 128 
M M M M M M M M I M I M M M M M M M i 11111 M 1111111111 i 11111! 
Sbjct: 427 cctgtagcccacgtcgtagcaaaccaccaagtgg-aggagcagctggagtggctgagcca 485 
Query: 129 gcgcgccaacgccctcctggccaacggcatggatctcaaagacaaccaactagtggtgcc 188 
I M M M I I I I I I I I i r i l M M I I I M I I I I I I I M M I I I I I I I I I I I I I M I M I M 
Sbj ct: 486 gcgcgccaacgccctcctggccaacggcatggatctcaaagacaaccaactagtggtgcc 545 
Query: 189 agccgatgggttgtaccttgtctactcccaggttctcttcaagggacaaggctgccccga 248 
i m m m m m m m m m m m m i m m m m m i m m 
Sbjct: 546 agccgatgggttgtaccttgtctactcccaggttctcttcaagggacaaggctgccccga 605 
• # 
Query: 249 ctacgtgctcctcacccacaccgtcagccgatttgctatctca:taccaggagaaagtcaa 308 
I I I M I I I M I I I I I I I I I I I I I M M I I M M I I I I I I I I I I I M I I I I I I I I I I M M 
Sbjct: 606 ctacgtgctcctcacccacaccgtcagccgatttgctatctcataccaggagaaagtcaa 665 
Query: 309 cctcctctctgccgtcaagagccccttgccccaagggacacccctggagggggct 363 
IIIMIIIMIIIIIIiililllM illlllM I I I M M I M lllllllll 
Sbjct: 666 cctcctctctgccgtcaagagcccc-tgccccaa-ggacacccct-gagggggct 717 
Fig. 4.13 Results of sequencing for TNF-a. 
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〉gi1126219951gbIAFQ65922.21AFQ65922 Mus musculus strain SJL/J nitric oxide synthase 2 (Nos2) mRNA, 
complete cds 
Length = 3515 
Score = 347 bits (175), Expect = 3e-93 
Identities 二 220/232 (94%), Gaps = 5/232 (2%) • 
Strand 二 Plus / Plus 
Query: 60 gcagggccacctctacatttgcgganangtgcgcatggctcgggatgtggctaccacatt 119 
i m m m m m m m m I M I M M I M M M M M M M M M M M M 
Sbjct: 3260 gcagggccacctctacatttgcggagatgtgcgcatggctcgggatgtggctaccacatt 3319 
Query: 120 gaagaagctgggtnggccaccaagctgaacttggagcgaggagcaggtggaagactattt 179 
M M I M I I I I I I I I I I M I I I I M I I M i m m m m m m m m 丨 丨 
Sbjct: 3320 gaagaagctgg--tggccaccaagctgaactt-gagcgaggagcaggtggaagactattt 3376 
Query 180 cttccagctcaagagccagaaacgttatcatnaagatatcttcggtgcagtcttttccta 239 
i m m m m m m m m m m I I I I I M M M I I I I M M M I I M I M 
Sbjct: 3377 cttccagctcaagagccagaaacgttatcatgaagatatcttcggtgcagtcttttccta 3436 � 
Query: 240 tggggcaaaaaagggcaccgccttgggaggannccaaaagccacgaggctct 291 
i m m m m m 丨 m m m m 丨丨 M I I I I I I I I I M I I I 
Sbjct: 3437 tggggcaaaaaagggcagcgcc11-ggaggagccc-aaagccacgaggctct 3486 





5.1 Characterization of TAP Fractions 
In order to extract crude TAP, Tremella aurantialba was subjected to prolonged 
hot water extraction. By doing so, polysaccharide in fungal cell wall could also be 
extracted and isolated. Ethanol was added to precipitate large molecular weight 
components such as polysaccharide. Using anion exchange chromatography, 
components in the crude TAP could be further separated by ionic charge. The 
suitable ionic strength ofNaCl was determined with the aid of a gradient mixer using 
NaCl solution ranged from 0 - 1 M . Preliminary study showed that peaks containing 
polysaccharides appeared at concentrations: 0, 0.04 and 0.1 M (data not shown). TAP 
1 was eluted by distilled water, thus it is a neutral polysaccharide fraction that could 
not bind to a DEAE-cellulose column. TAP 2 as well as TAP 3 are both acidic 
polysaccharides and uronic acid residues were presence in the fractions (Table 4.4). 
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Besides, the results in Table 4.4 support that TAP 3 having a higher ionic strength 
than TAP 2 as TAP 3 contains higher amount of uronic acid residues. 
Although none of the compounds in the three TAP fractions line within the 
molecular mass of standard curve of dextran standards (25-650 kDa) using HPLC, 
the approximate molecular mass of each component in the TAP fractions could still 
be deduced. TAP 1 is a fraction contained only 0.13 m g polysaccharide and 0.10 m g 
proteins per m g of sample. The percentage of polysaccharide in it is rather low. 
H P L C showed that TAP 1 contains two main fractions. One of them has a large 
molecular weight (>650 kDa) while the other has a relatively low molecular weight 
(<25 kDa). 
TAP 2 consists 81% polysaccharide and 15% protein by weight. H P L C of TAP 
2 showed that it consists two fractions, one is relatively large (>650 kDa) and the 
other is relatively smaller (<25 kDa). However, TAP 3 is a rather pure fraction. Its 
main constituent has a molecular weight over 650 kDa as estimated by HPLC. It 
contains only 0.02 m g of protein but 0.92 m g polysaccharide per m g of sample. 
In this project, phenol-sulfuric assay is used to determine the approximate 
polysaccharide content within a sample. This method is a convenient and accurate 
method to detect polysaccharide even if it is available only at low level. However, 
the standard curve constructed using different monosaccharide may be more or less 
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different according to Dubois et al” 1956 (Fig 5.1). Besides, polysaccharides from 
mushrooms may compose of different monosaccharide but only one kind of 
monosaccharides can be used in the standard curve. Therefore, selection of 
monosaccharide as a standard is very critical. Since the result of G C showed that 
TAP fractions contained high percentage of mannose, it is used as a standard in this 
experiment. 
Though phenol sulfuric acid assay has such limitation, it is still used in this 
study for many reasons. Firstly, it is a simple, quick method that produces stable and 
reproducible results. The reagents used in this test are stable, inexpensive and 
commonly available in laboratory. To detect the presence of polysaccharide in a large 
amount of fractions produced during anion exchange chromatography, its advantages 
outweigh the shortcomings. 
As compared with other bioactive polysaccharides isolated from the same genus, 
such as immunomodulating polysaccharide isolated from Tremella fuciformis by Gao 
Qt al (1996b) and anti-diabetic polysaccharide isolated from Tremella aurantia by 
Kiho et al (1995), the most effective fraction TAP 2, like the other two 
polysaccharides, contains high amount of mannose as detected by gas 
chromatography. This characteristic may be a common feature of polysaccharide 
isolated from the same genus, Tremella, However, the component sugar in TAP 2 and 
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Tremella aurantia polysaccharide extracted by Kiho et al (1995) are different. The 
major constituents of TAP 2 are mannose, xylose, glucose and galactose. The 
anti-diabetic polysaccharide isolated from Tremella aurantia by Kiho et al. (1995)， 
does not contain galactose. Besides, this anti-diabetic polysaccharide does not 
possess any protein residues but TAP 2 do. 
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Fig. 5.1 Standard curve prepared from different monosaccharides using phenol 
sulfuric acid assay (adapted from Dubois et al, 1956). 
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5.2 Antitumor Effects of TAP Fractions 
Most mushroom polysaccharides do not have direct toxicity towards normal 
cultured cells (Ooi & Lui, 2000). Therefore, it is not surprised that TAP fractions do 
not show direct cytotoxicity towards normal kidney cell line up to a dose of 1 mg/kg. 
Although TAP fractions do not show direct cytotoxicity towards normal cell line, 
surprisingly TAP 1 and 2 do show significant antiproliferative effect on particular 
cancer cell lines. O n the other hand, the rather pure fraction-TAP 3, like other 
mushroom polysaccharide such as lentinan (Chihara, 1992) and GL-B (Zhang & Lin, 
1999), does not possess any antitumor effect in vitro. This fraction even increased the 
proliferation rate of HL-60 and MCF-7 at dose 100 ^g/ml and 200 |ig/ml 
respectively. 
TAP 1 did not have any significant effect on suspension cell lines HL-60 and 
K-562. However, TAP 1 could inhibit the proliferation of the two adhesion cell lines, 
MCF-7 and HepG2 at lower doses (50 and 100 jig/ml). The highest inhibition ratio 
was observed in both cell lines at the lowest dose 50 |Lig/ml. This phenomenon might 
be due to the fact that TAP 1 is composed of more than one compound. Its anticancer 
effect of active substance in vitro is antagonized by the other components in TAP 1 
fraction at high dose. 
Among the three fractions，TAP 2 is the most effective in vitro. However, it does 
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not have significant effect on K-562 in vitro. TAP 2 could significantly inhibit the 
growth of three cancer cell lines, HL-60, MCF-7 and HepG2 in a dose-dependent 
manner. At a dose of 200 |ig/ml, TAP 2 could significantly reduce the proliferation of 
HL-60, MCF-7 and HepG2 by 44%, 20% and 33% respectively. Though mushroom 
polysaccharides rarely show anticancer effect in vitro, there are some exceptions. 
Some examples include PSP and PSK from Coriolus versicolor (Tsukagoshi et 
“/.，1984; Ng, 1998) as well as PSPC from Tricholoma lobayense (Liu et al； 1996b). 
However, the in vitro antitumor effect of TAP 2 was less effective when compared to 
PSPC. Liu et al. (1996b) reported that PSPC could inhibit the growth of HL-60 by 
63.8% at a dose of 60 |ag/ml, whereas TAP 2 could only inhibit the growth of HL-60 
by 44% even at a dose of200 jig/ml 
TAP 2 shows the most prominent effect among the three fractions and it could 
most effectively inhibit the growth of HL-60 cells. Therefore, the effect of TAP 2 on 
HL-60 was analyzed using Coulter counter again to further confirm the result. 
Similar trend of dose-dependent effect was observed. However, the highest inhibition 
ratio was decreased from 44% to 27% at dose 200 |ag/ml. The decrease in inhibition 
ratio may be due to the difference in the means of method used in evaluating the cell 
density. When screening the effect of TAP fractions on different cell lines, the cell 
numbers were counted by Trypan blue exclusion method using hemocytometer. 
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However, in order to further confirm the effect of TAP 2，more specific equipment, 
that is, the Coulter counter was used. Although Coulter counter is more accurate, it 
was not used in screening the effect of TAP fractions at the beginning of experiment. 
This is because determination of cell density by Coulter counter requires large 
amount of sample, media and cells for each trial. Therefore, the effect of TAP 
fractions was first screened by more economical method, that is, the Trypan blue 
exclusion method. In addition to the evaluation of cell number, Coulter counter also 
determines the cell diameter of each cancer cell. The results showed that TAP 2 
could significantly increase the cell diameter by 1-2%. This observation may rule out 
the possibility that TAP 2 inhibit the proliferation of HL-60 through apoptosis 
because apoptosis is usually coupled with a decrease in cell size before cell death. 
This hypothesis is further supported by the preliminary study done recently with the 
aid of flow cytometry. 
In the flow cytometry study, TAP 2 with a dose of 100 |ag/ml was incubated 
with HL-60 cells for 72 h. The result was analyzed by a FACSvantage flow 
cytometer (Becton Dickinson). D N A histograms plotting the relative cell number 
against the D N A content within a population were then constructed (Fig. 5.2). From 
the D N A histogram, the first peak indicats the cells in the HL-60 population that 
were in GO/Gl phase of the cell cycle. The second peak that had their D N A content 
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doubled indicates the subpopulation that was in G2/M phase. The subpopulation in 
between was those cells in S phase. If there were apoptosis or necrosis of cells 
happened within the population, a peak with D N A content lower than that of the 
Gl/GO phase would be observed. 
From the result (Fig. 5.2), TAP 2 did not cause the apoptosis or necrosis HL-60 
cells. However, the peak representing Gl/M phase was lowered in TAP 2-treated 
cells. This indicates that the percentage of cells that were in Gl/M phase within that 
population is lowered possibly due to the presence of TAP 2. Therefore, the in vitro 
anticancer effect of TAP 2 may cause by arresting the HL-60 cell at GO/Gl or S 
phase. However, this study is only at a preliminary stage, the detail mechanism 
requires fiirther investigation. 
In the preliminary study, crude TAP at doses of 4, 20 and 100 mg/kg was used 
�� 
to determine whether crude TAP could inhibit the growth of solid tumor in Sarcoma 
180-bearing mice. The results showed that at all doses, crude TAP could inhibit 
Sarcoma 180 proliferation in vivo but the effect was optimum at dose 20 mg/kg (data 
not showed). Therefore, crude TAP at 20 mg/kg was used as a reference in studying 
the effect of TAP fractions in vivo. 
The increase in tumor weight might give a deception that the body weights of 
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calculating the percentage change in body weight of animal models. The result 
showed that TAP fraction did not affect the body weight of tumor bearing mice 
notably，both control and TAP-treated mice had a 1-7% increase in body weight. In 
this study, TAP fractions were administered either 24 h or 72 h after tumor 
implantation in order to determine whether early administration of TAP could give a 
better tumor inhibition ratio. In both experiments TAP fractions were administered 
for 10 consecutive days and the results were collected 9 days later. The only 
difference between two sets of experiments was the date of sample injection began. 
Surprisingly, those mice that had received TAP fractions administration earlier (24 h) 
showed a lower inhibition ratio than those that were administered later (72 h) for all 
fractions and doses. However, it is not necessarily mean that TAP fractions show a 
better performance when administered 72 h after tumor implantation. Possibly, the 
� 
TAP fractions may produce an antiproliferative effect which ceases the tumor growth. 
It is supported by the fact that at the end of the experiment, the tumor weights of the 
TAP treated groups in the two sets of studies were similar, ranging from 0.23 to 0.43 
g for 24 h whereas for 72 h the tumor weight ranged from 0.20 to 0.40 g. The main 
reason accounted for the difference in tumor inhibition ratio is probably due to the 
difference in the tumor size of control group in the two experiments. The longer 
tumor implantation period in 72 h group enables the tumors in control group grow to 
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a larger size. This may be the reason why early administration of TAP fractions 
produces lower tumor inhibition ratio. 
All TAP fractions showed significant inhibitory effects on Sarcoma 180 solid 
tumor. However, for TAP 1 and 3, the inhibitory effects are decreased at high dose. 
As discussed in Section 2.4, though mushroom polysaccharides usually show a dose 
dependent inhibitory effect, some of them have their optimum dose. 
Although both TAP fractions possess antitumor effect in vivo, the most effective 
one is TAP 2. TAP 2 at a dose of 4 mg/kg showed 73.3% tumor inhibition. Even 
though it is hard to compare the effect of TAP 2 to other mushroom polysaccharides 
in vivo due to the difference in strain of mice and cancer cell lines used, complete 
regression of tumor in TAP 2-treated mice were less frequently (only 1/6 at dose 4 
mg/kg) seen when compared to well known mushroom polysaccharide such as 
� 
lentinan. Lentinan, a mushroom polysaccharide that already used clinically, is 
capable to cause complete regression in all lentinan-treated Sarcoma 180 solid 
tumor-bearing ICR mice at dosage only 1 mg/kg once a day for 10 days (Chihara et 
cd., 1970). As compared to lentinan, percentage of tumor-bearing mice with complete 
regression in the TAP treatement groups is much lower. This may be due to the 
multiple components present in TAP 2 fraction. Purification of bioactive component 
responsible for TAP 2 antitumor ability may further increase its activity. 
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After in vitro and in vivo study, the antitumor effect of TAP 2 was found to be 
the most prominent among the three fractions. In order to find out whether TAP 2 
also produces immunomodulatory effects as other mushroom polysaccharides do or 
is tumoricidal by causing direct cytotoxicity towards tumor cells, the m R N A 
expression level of cytokines and nitric oxide synthase in TAP 2-treated mice were 
studied. 
Cytokines work as a cascade of events. That is, the presence of particular 
cytokine(s) will induce the secretion of other cytokine(s) and so on. In the immune 
system, their functions may be unique or overlapped, stimulatory or inhibitory. For 
example, IL-2 and IFN-y can activate proliferation and differentiation of T cells 
whereas TGF-P can inhibit megakaryocytopoiesis. Cytokines show a high turnover 
rate and the cytokines express at this moment may not be detected in the next 
moment (Kelso, 1998; Oldham, 1998a & b). 
Therefore, the results in this study just indicate the cytokine m R N A expression 
level at that particular time, that is, 24 h after the Lp. injection of TAP 2. At this 
particular moment, the mice have received sufficient stimuli by TAP 2 and hopefully 
the effector molecule(s) in the immune system activated by TAP 2 administration 
may be found out. 
The m R N A expression level and cytokines being activated are different in 
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splenocytes (SPC) and peritoneal exduate cells (PEC) isolated from TAP 2-treated 
mice as illustrated in Chapter 4. However, from the result obtained, m R N A s oflL-ip 
and TNF-a are upregulated in both SPC and PEC of TAP 2-treated mice. These two 
cytokines are important in activating macrophages (Gale & Sorokin^ 2001; Brophy, 
2001). The activated macrophages will in turn produce more IL-1 and TNF-a. 
Therefore, TAP 2 might produce its antitumor effect through macrophage activation 
by induction of IL-1 and TNF-a. 
H o w does TAP 2 exhibit its antitumor effect through macrophage activation? 
The role of IL-1 P and TNF-a involved in antitumor activity should be clarified first. 
Though IL-1 a and IL-ip are examined in this study, only m R N A of IL-ip was 
upregluated. Although IL-1 a and IL-ip locate on different loci, they share the same 
receptor and having similar functions (Gale & Sorokin^ 2001). IL-1 possesses direct 
cytotoxic effect on cancer cell lines and indirect antitumor effect through the 
activation of natural killer cells or monocytes. IL-1 also causes the induction of other 
cytokines which are also tumoricidal (Gale & Sorokin^ 2001). For example, IL-1 can 
activate macrophages in an autocrine manner to produce more IL-1 and TNF-a (Gale 
& Sorokin, 2001; Brophy, 2001). The TNF-a produced is well known for its ability 
to kill cancer cells through direct induction of cell death by apoptosis and necrosis 
(Brophy, 2001). Its function is further enhanced if IL-1 is present. In turn, TNF-a 
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also activates macrophages in an autocrine manner to produce more TNF-a and IL-1 
(Gale & Sorokin^ 2001; Brophy, 2001). 
In addition to TNF-a and IL-ip, m R N A of nitric oxide synthase was also 
activated in PEC of TAP 2-treated mice. Nitric oxide (NO) is a minute molecule that 
causes direct cytotoxic effect on cancer cell lines and the production of N O involves 
an inducible enzyme N O synthase (NOS). Two cytokines are believed to be 
responsible for the induction of N O production, i.e. IFN-y and TNF-a. IFN-y 
produced by activated T helper cell is needed to stimulate macrophages to undergo 
synthesis of N O first. Then production of N O will be possible if TNF-a is present 
(Anbar, 1995; Roitt et al, 1998). Unfortunately, in the present study the m R N A of 
IFN-y was not detected in the treatment group though the pathway of synthesis N O 
was triggered (because the upregulation of m R N A of N O S was detected). This is 
probably because IFN-y has completed its role and decreased to a level that become 
undetectable at the moment the mice were killed. 
From the above speculations, TAP 2 may exhibit its antitumor effect through 
several pathways (1) direct cytotoxicity by TNF-a, (2) phagocytosis of tumor cells 
by activated macrophages，(3) activation of natural killer cells to kill tumor cells and 
(4) direct cytotoxicity by N O (Fig. 5.3). 
One interesting result was observed when comparing the m R N A expression 
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level ofTGF-p in SPC and PEC in TAP 2-treated mice. TGF-P was upregulated in 
SPC but it was down regulated in PEC of TAP 2-treated mice. TGF-p, like other 
cytokines, has various functions. Besides its inhibitory action on 
megakaryocytopoiesis, it can also act as a chemoattractant to attract monocyte and 
marcophage, and to induce them to produce TNF and IL-1. Therefore, it is not 
surprising that TGF-p was upregulated in SPC in TAP 2 -treated mice to recruit more 
activated macrophage. However, why TGF-P is down regulated in PEC remains 
unclear. It may be because overproduction of IL-1 and TNP-a are actually harmful to 
the host. As the mice received TAP 2 was not tumor-bearing mice, when IL-1 raised 
to a certain level, TFG-(3 was down regulated in TAP-2 treated mice to maintain the 
homeostasis of host immune system. 
Though m R N A of IL-12 p35 and p40 were upregulated in SPC of TAP 2 
� 
-treated mice, the IL-12 produced might not be functional. A functional IL-12 is a 
heterodimer composed ofsubunits p35 and p40 (D'Andrea et al., 1992; Lewko et al., 
1998). These two subunits are two separate gene products located on different 
chromosomes. Many cells synthesize p35 without producing p40 (Lewko et aL, 
1998). However, fiinctional IL-12 heterodimer is only secreted when there is an 
excess production of p40 over p35. Thus, the production of IL-12 is controlled by the 




amount of m R N A of IL-12 p40 was upregulated in SPC. Hence, TAP 2 might not 
induce the mice to produce functional IL-12 heterodimer (D'Andrea et al., 1992; 
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Fig 5.3 Proposed antitumor mechanism of TAP 2 
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5.3 Further Study 
In this study, the antitumor effect of Tremella aurantialba polysaccharides was 
investigated. Among the three fractions examined, TAP 2 showed the most 
prominent effect in vitro and in vivo. However, TAP 2 was still not a pure compound 
and further purification should be done in the future in order to find out what the 
active component inside the TAP 2 fraction is responsible for its bioactivity. TAP 2 
contains into two fractions as determined by HPLC study, one having a molecular 
weight larger than 650kDa and the other one having molecular weight between 
12-25kDa. A Sephadrose column may use to fiirther purify fractions in TAP 2 
according to their molecular sizes. 
Even though many efforts have been attempted in identifying the antitumor 
effect of TAP 2 in this study, the mechanisms of TAP 2 in vitro and in vivo are still 
not fiiUy elucidated. Though a preliminary study by flow cytometry showed that TAP 
2 might act on HL-60 cell line through modulation of cell cycle, it might not be the 
same case in other cell lines (e.g. HepG2 and MCF-7). Besides, it is not known 
which component in TAP 2 is responsible for its anticancer activity in vitro. Will it 
be the one accounts for TAP 2 antitumor effect in vivo? These questions require 
further investigation with the aid of flow cytometry. 
The immunomodulatory activity of TAP 2 might account for its antitumor effect 
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in vivo. Mice administered TAP 2 showed an elevation of the m R N A expression 
levels of IL-1 p, TNF-a and NOS. However, the production of cytokines (or enzyme) 
is tightly regulated. The expression of m R N A may not necessarily mean that there 
will be a cytokine secretion. Therefore, further investigation of the "product" is 
needed. For example, the secretion of TNF-a can be quantitatively determined by 
using L929 cell line whereas the presence of N O can be detected by a colorimetric 






In this study, three TAP fractions (TAP 1, 2 and 3) were prepared from Tremella 
aurantialba after prolonged hot water extraction and anion chromatography. A series 
of in vitro and in vivo experiments showed that TAP 2 was the fraction having most 
prominent antitumor effect. 
TAP 2 consisted 81% polysaccharide and 15% protein by weight. HPLC of TAP 2 
� 
indicated that it has two fractions, one is relatively larger (>650 kDa) and the other is 
relatively smaller (12-25 kDa). The major constituents of TAP 2 were maimose, xylose, 
glucose and galactose as detected by gas chromatography. 
TAP 2 did not have direct cytotoxicity towards normal kidney cell line up to a 
dose of 1 mg/kg. However, TAP 2 had antiproliferative effect on particular cancer cell 
lines in vitro. It could significantly inhibit the growth of three cancer cell lines, HL-60， 
MCF-7 and HepG2 in a dose-dependent maimer. At a dose of 200 jig/ml, TAP 2 could 
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Significantly reduce the proliferation of HL-60，MCF-7 and HepG2 by 44%，20% and 
33% respectively. However, the in vitro antitumor effect of TAP 2 is less effective 
when compared to PSPC isolated from Tricholoma lobayense (Liu et al； 1996b). TAP 
2 did not cause apoptosis or necrosis HL-60 cells at dose 100 i^g/ml as analyzed by 
Coulter counter and flow cytometry. The in vitro anticancer effect of TAP 2 might 
cause by arresting the HL-60 cell at GO/Gl or S phase. 
Although all TAP fractions possess antitumor effect in vivo, the most effective one 
is TAP 2. TAP 2 at a dose of 4 mg/kg (for 10 consecutive days) showed 73.3% tumor 
inhibition. However, complete regression of tumor in TAP 2-treated mice was not 
frequent (only 1/6 at dose 4 mg/kg). 
The immunomodulatory activity of TAP 2 might account for its antitumor effect 
in vivo. From the study on the m R N A expression level of cytokines an nitric oxide 
synthase in TAP 2-treated mice, an elevation of the m R N A expression levels of IL-ip, 
TNF-a and N O S in mice administered TAP 2 was observed. The data suggested that 
TAP 2 might exhibit its antitumor effect through several pathways (1) direct 
cytotoxicity by TNF-a, (2) phagocytosis of tumor cells by activated macrophage, (3) 
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